10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

x Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2019.

or

¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number: 001-35376

GLOWPOINT, INC.
(Exact Name of Registrant as Specified in its Charter)

Delaware (State or Other Jurisdiction of
Incorporation or Organization) 77-0312442 (I.R.S. Employer Identification No.)

999 18th Street, Suite 1350S, Denver, CO, 80202

(Address of Principal Executive Offices, including Zip Code)

(303) 640-3838
(Registrant’s Telephone Number, including Area Code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001 per share	GLOW	NYSE American

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes x  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o	Accelerated filer o
Non-accelerated filer x	Smaller reporting company x
	Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)

Yes o No x

The number of shares outstanding of the registrant’s common stock as of May 10, 2019 was 5,092,000.

GLOWPOINT, INC.

Index

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements		1
	Condensed Consolidated Balance Sheets at March 31, 2019 (unaudited) and December 31, 2018	1
	Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2019 and 2018	2
	Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the three months ended March 31, 2019 and 2018	3
	Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2019 and 2018	4
	Notes to unaudited Condensed Consolidated Financial Statements	5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		14
Item 3. Quantitative and Qualitative Disclosures About Market Risk		16
Item 4. Controls and Procedures		17
PART II - OTHER INFORMATION
Item 1. Legal Proceedings		17
Item 1A. Risk Factors		17
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		17
Item 3. Defaults Upon Senior Securities		18
Item 4. Mine Safety Disclosures		18
Item 5. Other Information		18
Item 6. Exhibits		19
Signatures		20

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q (this “Report”) contains statements that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and its rules and regulations (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, and its rules and regulations (the “Exchange Act”). These forward-looking statements include, but are not limited to, statements about the plans, objectives, expectations, and intentions of Glowpoint, Inc. (“Glowpoint” or “we” or “us” or the “Company”). All statements other than statements of current or historical fact contained in this Report, including statements regarding Glowpoint’s future financial position, business strategy, budgets, projected costs, and plans and objectives of management for future operations, are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” and similar expressions, as they relate to Glowpoint, are intended to identify forward-looking statements. These statements are based on Glowpoint’s current plans, and Glowpoint’s actual future activities and results of operations may be materially different from those set forth in the forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. Any or all of the forward-looking statements in this Report may turn out to be inaccurate. Glowpoint has based these forward-looking statements largely on its current expectations and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy, and financial needs. The forward-looking statements can be affected by inaccurate assumptions or by known or unknown risks, uncertainties, and assumptions. There are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including our plans, objectives, expectations and intentions and other factors that are discussedunder the section entitled “Part I. Item 1A. Risk Factors” and in our consolidated financial statements and the footnotes thereto for the fiscal year ended December 31, 2018, each included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 filed with the Securities and Exchange Commission (the “SEC”) on March 8, 2019, as well as under “Part II. Item 1A. Risk Factors” in this Report. Glowpoint undertakes no obligation to publicly revise these forward-looking statements to reflect events occurring after the date hereof. All subsequent written and oral forward-looking statements attributable to Glowpoint or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements contained in this Report. Forward-looking statements in this Report include, among other things: our expectations and estimates relating to customer attrition, sales cycles, future revenues, expenses and cash flows; evolution of our customer solutions and our service platforms; our anticipated capital expenditures; our ability to fund operations; our ability to identify, execute and finance any alternative options for organic or strategic growth and/or investments in product development and sales and marketing; expectations regarding adjustments to our cost of revenue and other operating expenses; our expectations regarding the effect of the termination of our previously existing merger agreement with SharedLabs; our ability to raise capital through sales of additional equity securities; our ability to continue as a going concern; and adequacy of our internal controls. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those summarized below:

• customer acceptance and demand for our video collaboration services and network applications;

• the quality and reliability of our services;

• the prices for our services;

• customer renewal rates;

• risks related to the concentration of our customers and the degree to which our sales, now or in the future, depend on certain large client relationships;

• customer acquisition costs;

• our ability to compete effectively in the video collaboration services and network services businesses;

• actions by our competitors, including price reductions for their competitive services,

• potential federal and state regulatory actions;

• our need for and the availability of adequate working capital;

• our ability to innovate technologically;

• our ability to satisfy the standards for continued listing of our common stock on the NYSE American stock exchange;

• changes in our capital structure and/or stockholder mix;

• the costs, disruption, and diversion of management’s attention associated with campaigns commenced by activist investors;

• our management’s ability to execute its plans, strategies and objectives for future operations; and

• the impact of the termination of our previously existing merger agreement with SharedLabs, and our ability to recover any damages owing from SharedLabs under the terms of the merger agreement.

GLOWPOINT, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value, stated value, and shares)

	March 31, 2019			December 31, 2018
	(Unaudited)
ASSETS
Current assets:
Cash	$	1,589		$	2,007
Accounts receivable, net	1,442			1,371
Prepaid expenses and other current assets	619			547
Total current assets	3,650			3,925
Property and equipment, net	610			728
Goodwill	2,795			2,795
Intangibles, net	467			499
Other assets	89			15
Total assets	$	7,611		$	7,962
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	207			222
Accrued expenses and other liabilities	1,159			910
Total current liabilities	1,366			1,132
Commitments and contingencies (see Note 9)
Stockholders’ equity:
Preferred stock Series A-2, convertible; $.0001 par value; $7,500 stated value; 7,500 shares authorized, 32 shares issued and outstanding and liquidation preference of $323 and $308 at March 31, 2019 and December 31, 2018, respectively	—			—
Preferred stock Series B, convertible; $.0001 par value; $1,000 stated value; 2,800 shares authorized, no shares issued and outstanding and liquidation preference of $0 at March 31, 2019 and 75 shares issued and outstanding and liquidation preference of $75 at December 31, 2018	—			—
Preferred stock Series C, convertible; $.0001 par value; $1,000 stated value; 1,750 shares authorized, 475 shares issued and outstanding and liquidation preference of $475 at March 31, 2019 and 525 shares issued and outstanding and liquidation preference of $525 at December 31, 2018	—			—
Common stock, $.0001 par value; 150,000,000 shares authorized; 5,173,900 issued and 5,040,500 outstanding at March 31, 2019 and 5,113,700 issued and 4,981,200 outstanding at December 31, 2018	5			5
Treasury stock, 133,400 and 132,500 shares at March 31, 2019 and December 31, 2018, respectively	(497		)	(496		)
Additional paid-in capital	185,008			184,994
Accumulated deficit	(178,271		)	(177,673		)
Total stockholders’ equity	6,245			6,830
Total liabilities and stockholders’ equity	$	7,611		$	7,962

See accompanying notes to condensed consolidated financial statements.

- 1-

GLOWPOINT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

	Three Months Ended
	March 31,
	2019			2018
Revenue	$	2,594		$	3,474
Operating expenses:
Cost of revenue (exclusive of depreciation and amortization)	1,675			2,147
Research and development	213			250
Sales and marketing	33			177
General and administrative	1,112			898
Impairment charges	—			650
Depreciation and amortization	159			232
Total operating expenses	3,192			4,354
Loss from operations	(598		)	(880		)
Interest and other expense, net	—			(405		)
Net loss	(598		)	(1,285		)
Preferred stock dividends	15			3
Net loss attributable to common stockholders	$	(613	)	$	(1,288	)
Net loss attributable to common stockholders per share:
Basic and diluted net loss per share	$	(0.12	)	$	(0.28	)
Weighted-average number of shares of common stock:
Basic and diluted	5,104			4,623

See accompanying notes to condensed consolidated financial statements.

- 2-

GLOWPOINT, INC.

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

Three Months Ended March 31, 2019 and 2018

(In thousands, except shares of Series A-2, Series B and Series C Preferred Stock)

(Unaudited)

	Series A-2 Preferred Stock			Series B Preferred Stock				Series C Preferred Stock				Common Stock			Treasury Stock				Additional Paid-In Capital			Accumulated Deficit
	Shares	Amount		Shares		Amount		Shares		Amount		Shares	Amount		Shares	Amount									Total
Balance at December 31, 2017	32	$	—	450		$	—	—		—		4,516	$	5	65	$	(352	)	$	183,114		$	(170,505	)	$	12,262
Net loss	—	—		—		—		—		—		—	—		—	—			—			(1,285		)	(1,285		)
Stock-based compensation	—	—		—		—		—		—		—	—		—	—			50			—			50
Issuance of preferred stock, net of expenses	—	—		—		—		1,750		—		—	—		—	—			1,527			—			1,527
Preferred stock conversion	—	—		(75	)	—		(475	)	—		185	—		—	—			—			—			—
Issuance of stock on vested restricted stock units	—	—		—		—		—		—		31	—		—	—			—			—			—
Preferred stock dividends	—	—		—		—		—		—		—	—		—	—			(3		)	—			(3		)
Purchase of treasury stock	—	—		—		—		—		—		—	—		18	(53		)	—			—			(53		)
Balance at March 31, 2018	32	$	—	375		$	—	1,275		$	—	4,732	$	5	83	$	(405	)	$	184,688		$	(171,790	)	$	12,498

	Series A-2 Preferred Stock			Series B Preferred Stock				Series C Preferred Stock				Common Stock			Treasury Stock				Additional Paid-In Capital			Accumulated Deficit
	Shares	Amount		Shares		Amount		Shares		Amount		Shares	Amount		Shares	Amount									Total
Balance at December 31, 2018	32	$	—	75		$	—	525		—		5,114	$	5	133	$	(496	)	$	184,994		$	(177,673	)	$	6,830
Net loss	—	—		—		—		—		—		—	—		—	—			—			(598		)	(598		)
Stock-based compensation	—	—		—		—		—		—		—	—		—	—			29			—			29
Preferred stock conversion	—	—		(75	)	—		(50	)	—		43	—		—	—			—			—			—
Issuance of stock on vested restricted stock units	—	—		—		—		—		—		17	—		—	—			—			—			—
Preferred stock dividends	—	—		—		—		—		—		—	—		—	—			(15		)	—			(15		)
Purchase of treasury stock	—	—		—		—		—		—		—	—		—	(1		)	—			—			(1		)
Balance at March 31, 2019	32	$	—	—		$	—	475		$	—	5,174	$	5	133	$	(497	)	$	185,008		$	(178,271	)	$	6,245

See accompanying notes to condensed consolidated financial statements.

- 3-

GLOWPOINT, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three Months Ended March 31,
	2019			2018
Cash flows from operating activities:
Net loss	$	(598	)	$	(1,285	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	159			232
Bad debt expense (recovery)	(4		)	5
Amortization of debt discount, net of gain on extinguishment	—			104
Stock-based compensation	29			50
Impairment charges	—			650
Changes in operating assets and liabilities:
Accounts receivable	(67		)	(80		)
Prepaid expenses and other current assets	(72		)	19
Other assets	24			—
Accounts payable	(15		)	(28		)
Accrued expenses and other liabilities	136			(139		)
Net cash used in operating activities	(408		)	(472		)
Cash flows from investing activities:
Purchases of property and equipment	(9		)	(48		)
Net cash used in investing activities	(9		)	(48		)
Cash flows from financing activities:
Principal payments under borrowing arrangements	—			(1,832		)
Proceeds from Series C Preferred Stock issuance, net of expenses of $223	—			1,527
Purchase of treasury stock	(1		)	(53		)
Net cash used in financing activities	(1		)	(358		)
Decrease in cash and cash equivalents	(418		)	(878		)
Cash at beginning of period	2,007			3,946
Cash at end of period	$	1,589		$	3,068
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	$	—		$	316
Non-cash investing and financing activities:
Accrued preferred stock dividends	$	15		$	3

See accompanying notes to condensed consolidated financial statements.

- 4-

GLOWPOINT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2019

(Unaudited)

Note 1 - Business Description and Significant Accounting Policies

Business Description

Glowpoint, Inc. (“Glowpoint,” “we,” “us,” or the “Company”) is a managed service provider of video collaboration and network applications. Our services are designed to provide a comprehensive suite of automated and concierge applications to simplify the user experience and expedite the adoption of video as the primary means of collaboration. Our customers include Fortune 1000 companies, along with small and medium sized enterprises in a variety of industries. We market our services globally through a multi-channel sales approach that includes direct sales and channel partners. The Company was formed as a Delaware corporation in May 2000. The Company operates in one segment and therefore segment information is not presented.

On December 20, 2018, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Glowpoint Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Glowpoint (the “Merger Sub”), and SharedLabs, Inc. (“SharedLabs”), a privately held global software and technology services company located in Jacksonville, Florida. The Merger Agreement provided for the merger of the Merger Sub with and into SharedLabs, with SharedLabs surviving as a wholly-owned subsidiary of Glowpoint (the “Merger”), in exchange for the issuance of shares of the Company’s Common Stock, par value $0.0001 per share (“Common Stock”). On April 28, 2019, the Company, the Merger Sub and SharedLabs entered into a Mutual Termination Agreement (the “Termination Agreement”), which provides for, among other things, (i) the termination of the Merger Agreement, (ii) the reservation of all rights by the Company and the Merger Sub under the Merger Agreement, applicable law or otherwise, with respect to any claims now existing or hereafter arising out of or related to the Merger Agreement, and (iii) the release by SharedLabs of the Company and the Merger Sub and certain of their affiliates from any claims up to the effective time of the Termination Agreement. SharedLabs has agreed to work with the Company in good faith to reach a resolution with respect to the Company’s rights in connection with the termination of the Merger Agreement, including the payment by SharedLabs of fees and expenses in connection therewith. To the extent it is necessary, the Company expects to utilize available legal remedies in order to pursue the payment by SharedLabs of any such amounts. There can be no assurance that the Company will be able to obtain payment by SharedLabs of any fees and expenses it owes to Glowpoint in connection with the termination of the Merger Agreement under the terms of the Merger Agreement. The Company has not recorded any amounts related to such potential recoveries as of March 31, 2019 and will record any such amounts when and if the gain contingency is resolved.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Glowpoint and our 100%-owned subsidiary, GP Communications, LLC, whose business function is to provide interstate telecommunications services for regulatory purposes. All material inter-company balances and transactions have been eliminated in consolidation.

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2018. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2018 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q does not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2018 and

- 5-

notes thereto included in the Company's fiscal 2018 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 8, 2019 (the “2018 10-K”).

The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Reclassification

Certain prior year amounts have been reclassified to conform with the current year presentation.

Significant Accounting Policies

The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our 2018 10-K.

Leases

The Company determines if an arrangement is a lease at inception. For the Company’s operating leases, the right-of-use (“ROU”) assets represents the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Since all of the lease agreements do not provide an implicit rate, the Company estimated an incremental borrowing rate in determining the present value of the lease payments. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectations regarding the terms. Variable lease costs such as operating costs and property taxes are expensed as incurred.

Adopted Accounting Standards

In February 2016 the FASB issued ASU 2016-02, “Leases (Topic 842)”, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. On January 1, 2019, the Company adopted the new lease standard using the optional transition method under which comparative financial information will not be restated and continue to apply the provisions of the previous lease standard in its annual disclosures for the comparative periods. In addition, the new lease standard provides a number of optional practical expedients in transition. The Company elected the package of practical expedients. As such, the Company did not have to reassess whether expired or existing contracts are or contain a lease; did not have to reassess the lease classifications or reassess the initial direct costs associated with expired or existing leases.

The new lease standard also provides practical expedients for an entity's ongoing accounting. The Company elected the short-term lease recognition exemption under which the Company will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases. The Company elected the practical expedient to not separate lease and non-lease components for certain classes of assets (office buildings). For leases that qualify as short-term leases, the Company has elected to not apply the balance sheet recognition requirements of Topic 842, and instead we recognize the lease payments in the condensed consolidated statement of operations on a straight-line basis over the lease term.

On January 1, 2019, the Company recognized ROU assets and lease liabilities of approximately $99,000 and $111,000, respectively, using an estimated incremental borrowing rate of 7.75%. The ROU assets are recorded in other assets and the lease liabilities are recorded in accrued expenses on the Company’s consolidated balance sheet.

In June 2018 the FASB issued ASU 2018-07, “Compensation - Stock Compensation (Topic 718).” The guidance simplifies the accounting for share-based payments to non-employees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The new guidance expands the scope to include share-based payments granted to non-employees in exchange for goods or services used or consumed in an entity’s own operations and supersedes the guidance in ASC 505-50. Effective January 1, 2019, we adopted Topic 718 and this guidance did not have a material impact on our consolidated financial statements.

Recently Issued Accounting Pronouncements

In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The amendments introduce an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and

- 6-

supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. In addition, the amendments provide for a simplified accounting model for purchased financial assets with a more-than-insignificant amount of credit deterioration since their origination. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. We believe the effect of adopting this guidance on our consolidated financial statements and related disclosures will not be material.

Note 2 - Liquidity and Going Concern

As of March 31, 2019, we had $1,589,000 of cash and working capital of $2,284,000. For the three months ended March 31, 2019, we incurred a net loss of $598,000 and used $408,000 of net cash in operating activities.

Our capital requirements continue to depend on numerous factors, including the timing and amount of revenue, the expense to deliver our services, expense for sales and marketing, expense for research and development, capital improvements, the number of shares repurchased under the Company’s Stock Repurchase Program, the cost involved in protecting our intellectual property rights, expenses required to successfully pursue and execute any merger and acquisition and/or business development initiatives, and, our ability to recover any damages owing from SharedLabs under the terms of the Merger Agreement. The Company believes that, based on our current projection of revenue, expenses, capital expenditures and cash flows, it has sufficient resources to fund its operations for at least the next twelve months following the filing of this Report. However, there is no assurance the Company will be able to accomplish this during this period or in the future following such period. The Company is exploring business development initiatives to leverage its technology, including pursuing organic growth and strategic growth through merger and acquisition or partnership opportunities. We anticipate negative cash flow from operations for the remainder of 2019 and we believe additional capital will be required to fund investments in product development and sales and marketing as a means to reverse our negative revenue trends. While we expect to continue to adjust our cost of revenue and other operating expenses to partially offset the impact of revenue declines associated with our legacy services, we believe additional capital will likely be necessary to fund our operations over the longer term. In the event we need access to capital to fund operations or provide growth capital, we would likely need to raise capital in one or more equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company.

Note 3 - Reverse Stock Split

On April 17, 2019, the Company filed an amendment to its certificate of incorporation that effected a one-for-ten reverse stock split of the Company's issued and outstanding shares of common stock. The reverse stock split did not affect the number of authorized shares of the Company’s common stock or the par value of a share of the Company’s common stock. Proportionate adjustments were made to the per share exercise or conversion price and the number of shares issuable upon the exercise or conversion of all outstanding options and other convertible or exchangeable securities, including issued and outstanding shares of the Company’s convertible preferred stock. All shares of common stock, as well as the per share exercise or conversion price and the number of shares issuable upon the exercise or conversion of all outstanding options and other convertible or exchangeable securities, including issued and outstanding shares of the Company’s convertible preferred stock, presented in this Report have been retroactively adjusted to give effect to this reverse stock split.

Note 4 - Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following (in thousands):

	March 31, 2019		December 31, 2018
Accrued professional fees	$	447	$	246
Accrued compensation costs	272		189
Accrued sales taxes and regulatory fees	157		168
Other accrued expenses	105		223
Right to use lease liability	92		—
Accrued dividends on Series A-2 Preferred Stock	86		71
Deferred rent expense	—		13
Accrued expenses and other liabilities	$	1,159	$	910

Note 5 - Stock Repurchase Program

- 7-

On July 21, 2018, the Company’s Board of Directors authorized a stock repurchase program (the “Stock Repurchase Program”) granting the Company authority to repurchase up to $750,000 of the Company’s Common Stock. Under the Company’s Stock Repurchase Program, repurchases of Common Stock may be funded using the Company’s existing cash balance and/or future cash flows through repurchases made in the open market, in privately negotiated transactions, or pursuant to other means determined by the Company, in each case as permitted by securities laws and other legal requirements. The number of shares purchased under the Stock Repurchase Program and the timing of any purchases may be based on many factors, including the level of the Company’s available cash, general business conditions, and the pricing of the Common Stock. The Stock Repurchase Program does not obligate the Company to acquire a specific number of shares and may be suspended, modified, or terminated at any time. During the three months ended March 31, 2019, the Company repurchased 23 shares of Common Stock at an aggregate cost of $30, including commissions and fees. All shares of Common Stock repurchased under the Stock Repurchase Program are recorded as treasury stock. The Stock Repurchase Program does not have an expiration date. As of March 31, 2019, the Company had $673,000 remaining under the Stock Repurchase Program.

Note 6 - Preferred Stock

Our Certificate of Incorporation authorizes us to issue up to 5,000,000 shares of preferred stock. As of March 31, 2019, there were: (i) 100 shares of Perpetual Series B-1 Preferred Stock authorized and no shares issued or outstanding; (ii) 7,500 shares of Series A-2 Convertible Preferred Stock authorized and 32 shares issued and outstanding (the “Series A-2 Preferred Stock”); (iii) 2,800 shares of 0% Series B Convertible Preferred Stock (the “Series B Preferred Stock”) authorized and no shares issued and outstanding; (iv) 1,750 shares of Series C Preferred Stock authorized and 475 shares issued and outstanding; (v) 4,000 shares of Series D Convertible Preferred Stock authorized and no shares issued or outstanding; and (vi) 100 shares of Perpetual Series B Preferred Stock authorized and no shares issued or outstanding.

Series A-2 Preferred Stock

Each share of Series A-2 Preferred Stock has a stated value of $7,500 per share (the “A-2 Stated Value”), a liquidation preference equal to the A-2 Stated Value, and is convertible at the holder’s election into common stock at a conversion price per share of $21.60 as of March 31, 2019. Therefore, each share of Series A-2 Preferred Stock is convertible into 347 shares of common stock as of March 31, 2019. The conversion price is subject to adjustment upon the occurrence of certain events set forth in our Certificate of Incorporation.

The Series A-2 Preferred Stock is subordinate to the Series B-1 Preferred Stock but senior to all other classes of equity, has weighted average anti-dilution protection and, since January 1, 2013, has been entitled to cumulative dividends at a rate of 5% per annum, payable quarterly, based on the A-2 Stated Value and payable at the option of the holder in cash or through the issuance of a number of additional shares of Series A-2 Preferred Stock with an aggregate liquidation preference equal to the dividend amount payable on the applicable dividend payment date. As of March 31, 2019, the Company has recorded $86,000 in accrued dividends in “Accrued expenses and other liabilities” on the accompanying Condensed Consolidated Balance Sheet related to the remaining Series A-2 Preferred Stock outstanding. The Company, at its option, may redeem all or a portion of the Series A-2 Preferred Stock in cash at a price per share of $8,250 per share (equal to $7,500 per share multiplied by 110%) plus all accrued and unpaid dividends.

Series B Preferred Stock

During the three months ended March 31, 2019, 75 shares (constituting all issued and outstanding shares) of Series B Preferred Stock were converted to 26,786 shares of the Company’s common stock at the conversion price of $2.80 per share. As of March 31, 2019, no shares of Series B Preferred Stock remain issued and outstanding.

Series C Preferred Stock

In January 2018, the Company closed a registered direct offering of 1,750 shares of its Series C Preferred Stock for total gross proceeds to the Company of $1,750,000. The shares of Series C Preferred Stock were sold at a price equal to their stated value of $1,000 per share and are convertible into shares of the Company’s common stock at a conversion price of $3.00 per share. During the three months ended March 31, 2019, 50 shares of Series C Preferred Stock were converted to 16,667 shares of the Company’s common stock. As of March 31, 2019, 475 shares of Series C Preferred Stock remain issued and outstanding, which are convertible to 158,333 shares of the Company’s common stock.

- 8-

Subject to certain exceptions, the Company has agreed to provide the purchasers, during the period that the purchasers continue to hold Series C Preferred Stock, a right of participation for up to 100% of any future offering of its common stock or other securities or equity linked debt obligations until January 2020.

In addition, the Company has agreed that it will not enter into certain “fundamental transactions,” including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company’s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series C Preferred Stock including the Lead Investor and on terms with respect to the Series C Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series C Preferred Stock.

In accordance with ASC Topic 815, we evaluated whether our convertible preferred stock contains provisions that protect holders from declines in our stock price or otherwise couldresult in modification of the exercise price and/or shares to be issued under the respective preferred stock agreements based on a variable that is not an input to the fairvalue of a “fixed-for-fixed” option and require a derivative liability. The Company determined no derivative liability is required under ASC Topic 815 with respect to our convertible preferred stock. A contingent beneficial conversion amount is required to be calculated and recognized when and if the adjusted $21.60 conversion price of the Series A-2 Preferred Stock is adjusted to reflect a down round stock issuance. In the event there is an adjustment to the conversion price, our earnings per share calculations will be impacted by the resulting deemed dividend.

Note 7 - Stock Based Compensation

Glowpoint 2014 Equity Incentive Plan

On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company’s common stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company’s common stock, or returns thereon. A total of 440,000 shares of the Company’s common stock were initially available for issuance under the 2014 Plan. At the 2018 Annual Meeting of Stockholders held on May 31, 2018, the Company’s stockholders approved an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by 300,000 shares (the "Amendment"). As of March 31, 2019, 400 shares were available for issuance under the 2014 Plan.

Glowpoint 2007 Stock Incentive Plan

In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of March 31, 2019, options to purchase a total of 117,877 shares of common stock and 11,318 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan.

Glowpoint 2000 Stock Incentive Plan

In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the “2000 Plan”). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of March 31, 2019, options to purchase a total of 25 shares of common stock were outstanding under the 2000 Plan. No shares are available for issuance under the 2000 Plan.

Stock Options

For the three months ended March 31, 2019, no stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2019, is presented below:

- 9-

	Outstanding				Exercisable
	Number of Shares Underlying Options		Weighted Average Exercise Price		Number of Shares Underlying Options	Weighted Average Exercise Price
Options outstanding, December 31, 2018	118,003		$	19.90	118,003	$	19.90
Expired	(101	)	13.18
Options outstanding, March 31, 2019	117,902		$	19.90	117,902	$	19.90

Stock-based compensation expense related to stock options was $0 for the three months ended March 31, 2019 and 2018. There is no remaining unrecognized stock-based compensation expense for stock options as of March 31, 2019.

Restricted Stock Awards

As of March 31, 2019, 11,318 unvested restricted stock awards were outstanding. No activity occurred related to restricted stock awards during the three months ended March 31, 2019.

Stock-based compensation expense related to restricted stock awards is allocated as follows (in thousands):

	Three Months Ended
	March 31,
	2019		2018
General and administrative	2		10
	$	2	$	10

Certain restricted stock awards have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, compensation expense is recognized over the relevant performance period. For those awards not subject to performance criteria, the cost of the restricted stock awards is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.

The remaining unrecognized stock-based compensation expense for restricted stock awards as of March 31, 2019 was $138,000. Of this amount, $1,000 relates to time-based awards with a remaining weighted average period of 0.23 years. The remaining $137,000 of unrecognized stock-based compensation expense relates to performance-based awards for which expense will be recognized upon it becoming probable that the Company will achieve defined financial targets.

Restricted Stock Units

A summary of unvested restricted stock units (“RSUs”) outstanding as of, and changes made during, the three months ended March 31, 2019, is presented below:

	RSUs		Weighted Average Grant Price
Unvested restricted stock units outstanding, December 31, 2018	503,511		$	1.94
Granted	52,976		1.31
Vested	(16,826	)	8.37
Forfeited	(267	)	1.31
Unvested restricted stock units outstanding, March 31, 2019	539,394		$	1.68

The number of restricted stock units vested during the three months ended March 31, 2019 includes 877 shares withheld and repurchased by the Company from employees to satisfy $1,000 of tax obligations relating to the vesting of such shares. Such shares are included in “Purchase of treasury stock” during the three months ended March 31, 2019.

- 10-

As of March 31, 2019, 98,763 vested RSUs issued to non-employee directors remain outstanding as shares of common stock have not yet been delivered due to the deferred payment provisions set forth in these RSUs.

As of March 31, 2019, 497,061 unvested RSUs have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, stock-based compensation expense is recognized over the relevant performance period. As of March 31, 2019, 42,333 unvested RSUs have timed-based vesting provisions, and the cost of the RSUs is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.

Stock-based compensation expense related to RSUs is allocated as follows (in thousands):

	Three Months Ended
	March 31,
	2019		2018
Cost of revenue	$	4	$	5
Research and development	4		10
Sales and marketing	—		2
General and administrative	19		23
	$	27	$	40

The remaining unrecognized stock-based compensation expense for RSUs as of March 31, 2019 was $666,000. Of this amount $29,000 relates to time-based RSUs with a remaining weighted average period of 1.05 years. The remaining $637,000 of unrecognized stock-based compensation expense relates to performance-based RSUs for which expense will be recognized upon it becoming probable that the Company achieves defined financial targets or a change of control occurs.

Note 8 - Net Loss Per Share

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at March 31, 2019 and 2018, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant.

Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three months ended March 31, 2019 and 2018, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss).

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):

	Three Months Ended March 31,
	2019			2018
Numerator:
Net loss	$	(598	)	$	(1,285	)
Less: preferred stock dividends	15			3
Net loss attributable to common stockholders	$	(613	)	$	(1,288	)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share	5,104			4,623
Basic and diluted net loss per share	$	(0.12	)	$	(0.28	)

- 11-

The weighted-average number of shares for all periods presented includes 98,763 shares of vested RSUs, respectively, as discussed in Note 7.

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect:

	Three Months Ended March 31,
	2019	2018
Unvested restricted stock units	539,394	98,944
Unvested restricted stock awards	11,318	11,318
Outstanding stock options	117,902	119,179
Shares of common stock issuable upon conversion of Series A-2 Preferred	79,043	79,043
Shares of common stock issuable upon conversion of Series B Preferred	—	133,929
Shares of common stock issuable upon conversion of Series C Preferred	158,333	425,000

Note 9 - Commitments and Contingencies

Operating Leases

We lease two facilities in Denver, CO and Oxnard, CA that are under operating leases through December 31, 2019 and April 30, 2020, respectively. Both of these leases require us to pay increases in real estate taxes, operating costs and repairs over certain base year amounts. Rent expense for the three months ended March 31, 2019 and 2018 was $52,000 and $74,000, respectively, and is included in general and administrative expenses in the accompanying consolidated statements of operations.

Future minimum rental commitments under all non-cancelable operating leases as of March 31, 2019, are as follows (in thousands):

Year Ending December 31,	Short-Term Lease		ROU Lease		Total
Remaining 2019	$	61	$	66	$	127
2020	—		30		30
	$	61	$	96	$	157

The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands):

Year Ending December 31,
Remaining 2019	$	66
2020	30
Total cash payments remaining	$	96
Effect of discounting	(4		)
Total accrued lease liability	$	92

Operating cash flow supplemental information as of March 31, 2019:

On January 1, 2019, initial ROU assets of $99,000 were recognized as a non-cash addition with the adoption of the new lease standard. Cash paid for amounts included in the present value of the operating lease liabilities was $22,000 which was included within accrued expenses for the three months ended March 31, 2019.

Note 10 – Major Customers

Major customers are defined as direct customers or channel partners that account for more than 10% of the Company’s revenue. For the three months ended March 31, 2019, three major customers represented 28%, 21%, and 10%, respectively, of our revenue.

- 12-

Three customers represented 48%, 15%, and 11%, respectively, of our accounts receivable balance at March 31, 2019. For the three months ended March 31, 2018, two major customers represented 24% and 23%, respectively, of our revenue.

Note 11 - Geographical Data

For the three months ended March 31, 2019 and 2018, there was no material revenue attributable to any individual foreign country. Revenue by geographic area, based on customer location, is allocated as follows (in thousands):

	Three Months Ended March 31,
	2019		2018
Domestic	$	1,796	$	2,269
Foreign	798		1,205
Total Revenue	$	2,594	$	3,474

Long-lived assets were 100% located in domestic markets as of March 31, 2019 and December 31, 2018.

Note 12 - Subsequent Events

On April 17, 2019, the Company filed an amendment to its certificate of incorporation that effected a one-for-ten reverse stock split of the Company's issued and outstanding shares of common stock. See Note 3 for further discussion.

On April 28, 2019, the Company, the Merger Sub and SharedLabs entered into the Termination Agreement, under which the parties agreed, among other things, to terminate the Merger Agreement effective as of April 28, 2019. See Note 1 for further discussion.

- 13-

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

Glowpoint, Inc. (“Glowpoint,” “we,” “us,” or the “Company”) is a managed service provider of video collaboration and network applications. Our services are designed to provide a comprehensive suite of automated and concierge applications to simplify the user experience and expedite the adoption of video as the primary means of collaboration. Our customers include Fortune 1000 companies, along with small and medium sized enterprises in a variety of industries. We market our services globally through a multi-channel sales approach that includes direct sales and channel partners. The Company was formed as a Delaware corporation in May 2000. The Company operates in one segment and therefore segment information is not presented.

On December 20, 2018, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Glowpoint Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Glowpoint (the “Merger Sub”), and SharedLabs, Inc. (“SharedLabs”), a privately held global software and technology services company located in Jacksonville, Florida. The Merger Agreement provided for the merger of the Merger Sub with and into SharedLabs, with SharedLabs surviving as a wholly-owned subsidiary of Glowpoint (the “Merger”), in exchange for the issuance of shares of the Company’s Common Stock, par value $0.0001 per share (“Common Stock”). On April 28, 2019, the Company, the Merger Sub and SharedLabs entered into a Mutual Termination Agreement (the “Termination Agreement”), which provides for, among other things, (i) the termination of the Merger Agreement, (ii) the reservation of all rights by the Company and the Merger Sub under the Merger Agreement, applicable law or otherwise, with respect to any claims now existing or hereafter arising out of or related to the Merger Agreement, and (iii) the release by SharedLabs of the Company and the Merger Sub and certain of their affiliates from any claims up to the effective time of the Termination Agreement. SharedLabs has agreed to work with the Company in good faith to reach a resolution with respect to the Company’s rights in connection with the termination of the Merger Agreement, including the payment by SharedLabs of fees and expenses in connection therewith. To the extent it is necessary, the Company expects to utilize available legal remedies in order to pursue the payment by SharedLabs of any such amounts. There can be no assurance that the Company will be able to obtain payment by SharedLabs of any fees and expenses it owes to Glowpoint in connection with the termination of the Merger Agreement under the terms of the Merger Agreement.

As of March 31, 2019, the Company had $1,589,000 in cash and no debt. We have experienced declines in revenue in recent fiscal years, including a decline in revenue from $3,474,000 in the first quarter of 2018 to $2,594,000 in the first quarter of 2019. These revenue declines are primarily due to net attrition of customers and lower demand for our services given the competitive environment and pressure on pricing that exists in our industry. As part of our efforts to address this revenue decline, during the years ended December 31, 2017 and 2018, the Company invested a total of $2,069,000 in research and development and $732,000 in sales and marketing with the goal of enhancing both its existing offerings and developing new service offerings. However, after the Company signed a letter of intent with SharedLabs in October 2018, the Company significantly curtailed such investments in order to focus its efforts and resources on the completion of the Merger. Now that the Merger Agreement has been terminated, the Company is exploring business development initiatives to leverage its technology, including pursuing organic growth and strategic growth through merger and acquisition or partnership opportunities. In addition, the Company is implementing certain infrastructure cost reductions in order to improve its operating cash flow. However, the Company does not currently have an expected timeline for the development and release of new services and/or the generation of additional revenue with new services, and, therefore, if no alternative growth strategies are pursued the Company will likely continue to experience declines in revenue in the future. If the Company fails to make the necessary investments to develop new service offerings that achieve broad market acceptance on a timely basis, it will not be able to compete effectively and will likely experience continued declines in revenue and lower gross margins.

Results of Operations

Three Months Ended March 31, 2019 (the“2019First Quarter”) compared to Three Months Ended March 31, 2018 (the “2018First Quarter”)

Revenue. Total revenue decreased $880,000 (or 25%) to $2,594,000 in the 2019First Quarter from $3,474,000 in the 2018First Quarter. The following table summarizes the changes in components of our revenue, and the significant changes in revenue are discussed in more detail below.

- 14-

	Three Months Ended
	March 31,
	2019		2018
Revenue
Video collaboration services	$	1,566	$	1,944
Network services	965		1,185
Professional and other services	63		345
Total revenue	$	2,594	$	3,474

• Revenue for video collaboration services decreased $378,000 (or 19%) to $1,566,000 in the 2019First Quarter from $1,944,000 in the 2018First Quarter. This decrease is mainly attributable to lower revenue from existing customers (either from reductions in price or level of services) and loss of customers to competition.

• Revenue for network services decreased $220,000 (or 19%) to $965,000 in the 2019First Quarter from $1,185,000 in the 2018First Quarter. This decrease is mainly attributable to net attrition of customers and lower demand for our services given the competitive environment and pressure on pricing that exists in the network services business.

• Revenue for professional and other services decreased $282,000 (or 82%) to $63,000 in the 2019First Quarter from $345,000 in the 2018First Quarter. This decrease is mainly attributable to lower resale of video equipment.

We expect that the year-over-year negative revenue trend for the 2018First Quarter to the 2019First Quarter will continue for the foreseeable future given the dynamic and competitive environment for our services. We believe sales cycles associated with selling our services directly to enterprise IT organizations and through our channel partners typically range from six to eighteen months. These factors create uncertainty as to when, and if, we will be able to stabilize and ultimately grow our revenue (see “Part II. Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2018 10-K) for further discussion).

Cost of Revenue (exclusive of depreciation and amortization). Cost of revenue, exclusive of depreciation and amortization, includes all internal and external costs related to the delivery of revenue. Cost of revenue also includes taxes which have been billed to customers.

Cost of revenue decreased to $1,675,000 in the 2019First Quarter from $2,147,000 in the 2018First Quarter. This $472,000 (or 22%) decrease in cost of revenue is mainly attributable to lower costs associated with the $880,000 decrease in revenue during the same period. We reduced costs related to revenue in these areas during the 2019First Quarter: personnel costs, network costs, taxes, and external costs associated with video meeting suites. Cost of revenue, as a percentage of total revenue, increased to 65% for the 2019First Quarter from 62% for the 2018First Quarter, respectively. The increase in cost of revenue as a percentage of total revenue is mainly due to higher personnel costs as a percentage of total revenue.

Research and Development. Research and development expenses include internal and external costs related to developing new service offerings and features and enhancements to our existing services. Research and development expenses decreased to $213,000 in the 2019First Quarter from $250,000 in the 2018First Quarter. This decrease is primarily attributable to lower headcount and corresponding personnel costs.

Sales and Marketing Expenses. Sales and marketing expenses decreased to $33,000 in the 2019First Quarter from $177,000 in the 2018First Quarter. This decrease is primarily attributable to a decrease in third party marketing costs of $141,000 between the 2019 and 2018First Quarter.

General and Administrative Expenses. General and administrative expenses include direct corporate expenses and costs of personnel in the various corporate support categories, including executive, finance and accounting, legal, human resources and information technology. General and administrative expenses increased $214,000 (or 24%) to $1,112,000 in the 2019First Quarter from $898,000 in the 2018First Quarter. This increase is primarily attributable to $261,000 of advisory fees incurred in the three months ended March 31, 2019 relating to the previously proposed Merger with SharedLabs.

Impairment Charges. Impairment charges on goodwill were $650,000 in the 2018First Quarter as compared to none for the 2019First Quarter. The continued future decline of our revenue, cash flows and/or stock price may give rise to a triggering event that may require the Company to record impairment charges in the future related to our goodwill, intangible assets and other long-lived assets.

- 15-

Depreciation and Amortization Expenses. Depreciation and amortization expenses decreased to $159,000 in the 2019First Quarter from $232,000 in the 2018First Quarter. This $73,000 decrease is mainly attributable to lower depreciation expense due to an increase in assets which became fully depreciated during 2018 and 2019.

Loss from Operations. The Company recorded a loss from operations of $598,000 in the 2019First Quarter as compared to a loss from operations of $880,000 in the 2018First Quarter. The decrease in our loss from operations from the 2018First Quarter to the 2019First Quarter is mainly attributable to a decrease in goodwill impairment charges, partially offset by a decrease in gross margin (or revenue less cost of revenue) as discussed above.

Liquidity and Capital Resources

As of March 31, 2019, we had $1,589,000 of cash and working capital of $2,284,000. For the three months ended March 31, 2019, we incurred a net loss of $598,000 and used $408,000 of net cash in operating activities.

Net cash used in investing activities for the three months ended March 31, 2019 was $9,000 and primarily related to purchases of property and equipment. Net cash used in financing activities for the three months ended March 31, 2019 was $1,000, primarily attributable to repurchases of treasury stock from employees to satisfy minimum statutory tax withholding requirements.

Our capital requirements continue to depend on numerous factors, including the timing and amount of revenue, the expense to deliver our services, expense for sales and marketing, expense for research and development, capital improvements, the number of shares repurchased under the Company’s Stock Repurchase Program, the cost involved in protecting our intellectual property rights, expenses required to successfully pursue and execute any merger and acquisition and/or business development initiatives, and, our ability to recover any damages owing from SharedLabs under the terms of the Merger Agreement. The Company believes that, based on our current projection of revenue, expenses, capital expenditures and cash flows, it has sufficient resources to fund its operations for at least the next twelve months following the filing of this Report. However, there is no assurance the Company will be able to accomplish this during this period or in the future following such period. The Company is exploring business development initiatives to leverage its technology, including pursuing organic growth and strategic growth through merger and acquisition or partnership opportunities. We anticipate negative cash flow from operations for the remainder of 2019 and we believe additional capital will be required to fund investments in product development and sales and marketing as a means to reverse our negative revenue trends. While we expect to continue to adjust our cost of revenue and other operating expenses to partially offset the impact of revenue declines associated with our legacy services, we believe additional capital will likely be necessary to fund our operations over the longer term. In the event we need access to capital to fund operations or provide growth capital, we would likely need to raise capital in one or more equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company.

Off-Balance Sheet Arrangements

As of March 31, 2019, we had no off-balance sheet arrangements.

Inflation

Management does not believe inflation had a significant effect on the condensed consolidated financial statements for the periods presented.

Critical Accounting Policies

Other than the adoption of Topic 842 and Topic 718, for non-employees, there have been no changes to our critical accounting policies during the three months ended March 31, 2019. Critical accounting policies and the significant estimates made in accordance with such policies are regularly discussed with our Audit Committee. Those policies are discussed under “Critical Accounting Policies” in “Part II. Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in our consolidated financial statements and the footnotes thereto, each included in our 2018 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a “smaller reporting company” as defined by the rules and regulations of the SEC, we are not required to provide this information.

- 16-

Item 4. Controls and Procedures

Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2019. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, 2019, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms and are designed to ensure that information required to be disclosed by the Company in the reports we file or submit under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

No change in our internal control over financial reporting occurred during the fiscal quarter ended March 31, 2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are subject to various legal proceedings arising in the ordinary course of business, including proceedings for which we have insurance coverage. As of the date hereof, we are not party to any legal proceedings that we currently believe will have a material adverse effect on our business, financial position, results of operations or liquidity.

Item 1A. Risk Factors

A description of the risks associated with our business, financial conditions and results of operations is set forth in “Part I.Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the Securities and Exchange Commission on March 8, 2019 (the “2018 Annual Report”). As discussed under “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations--Overview” above, we entered into a Termination Agreement, dated April 28, 2019, which, among other things, terminated our previously existing Merger Agreement with SharedLabs.  As a result, many of the risks related to the Merger and set forth under “Part I. Item 1A. Risk Factors--Risks Related to the Proposed Merger with SharedLabs” are no longer applicable to us. Subject to the foregoing sentence, there have been no material changes to these risks during the three months ended March 31, 2019. The risks described in the 2018 Annual Report are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities by the Company

There have been no unregistered sales of securities by the Company during the period covered by this Report that have not been previously reported in a Current Report on Form 8-K.

Purchases of Equity Securities by the Company

Vesting of Stock Awards

During the period covered by this Report, the Company repurchased 877 shares of the Company’s Common Stock (and recorded such shares in treasury stock) from employees to satisfy $1,000 of minimum statutory tax withholding requirements relating to the vesting of stock awards.

Stock Repurchase Program

On July 21, 2018, the Company’s Board of Directors authorized a stock repurchase program (the “Stock Repurchase Program”) granting the Company authority to repurchase up to $750,000 of the Company’s Common Stock, par value $0.0001 per share

- 17-

(“Common Stock”). All shares of Common Stock repurchased under the Stock Repurchase Program are recorded as treasury stock. The Stock Repurchase Program does not have an expiration date. The table below shows the monthly activity related to our Stock Repurchase Program for the quarter ended March 31, 2019. The amounts given in the table have been retroactively adjusted to reflect the reverse stock split.

Period	Total Number of Shares Purchased (1)(2)	Average Price Paid Per Share (3)	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
January 1-31, 2019	900	$1.30	23	$673,000
February 1-28, 2019	—	—	0	$673,000
March 1-31, 2019	—	—	0	$673,000
Total	900	$1.30	23	$673,000
(1) 877 shares purchased by the Company during the period covered by this Report were purchased from employees to offset $1,000 of minimum statutory tax withholding requirements relating to the vesting of stock awards.
(2) As of March 31, 2019, the maximum number of shares that may yet be purchased by the Company would not exceed the employees’ portion of taxes withheld on the vesting of the following outstanding unvested equity awards: 11,318 shares of restricted stock, 117,902 stock options, and 539,394 restricted stock units, plus 374 shares yet to be granted under the 2014 Equity Incentive Plan as of March 31, 2019.
(3) Price per share includes commissions and fees.

As of March 31, 2019, the Company had $673,000 remaining for future repurchases of Common Stock under the Stock Repurchase Program.

Item 3. Defaults upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

- 18-

Item 6. Exhibits

Exhibit Number	Description
2.1	Mutual Termination Agreement, dated April 28, 2019, by and among Glowpoint, Inc., Glowpoint Merger Sub Inc., and SharedLabs, Inc. (filed as Exhibit 10.1 to Registrant’s Current Report on Form 8-K filed with the SEC on April 29, 2019, and incorporated herein by reference).
3.1	Amended and Restated Certificate of Incorporation (filed as Appendix D to View Tech, Inc.’s Registration Statement on Form S-4 (File No. 333-95145) filed with the SEC on January 21, 2000, and incorporated herein by reference).
3.2	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Wire One Technologies, Inc. changing its name to Glowpoint, Inc. (filed as Exhibit 3.2 to Registrant’s Annual Report on Form 10-K filed with the SEC on March 30, 2004, and incorporated herein by reference).
3.3	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Glowpoint, Inc. increasing its authorized common stock to 150,000,000 shares from 100,000,000 shares (filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K filed with the SEC on September 24, 2007, and incorporated herein by reference).
3.4	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Glowpoint, Inc. effecting a one-for-four reverse stock split of the common stock of Glowpoint, Inc. (filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K filed with the SEC on January 13, 2011, and incorporated herein by reference).
3.5*	Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Glowpoint, Inc. effecting a one-for-ten reverse stock split of the common stock of Glowpoint, Inc.
31.1*	Rule 13a—14(a)/15d—14(a) Certification of the Chief Executive Officer.
31.2*	Rule 13a—14(a)/15d—14(a) Certification of the Chief Financial Officer.
32.1**	Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation Linkbase
101.DEF	XBRL Taxonomy Extension Definition Linkbase
101.LAB	XBRL Taxonomy Extension Label Linkbase
101.PRE	XBRL Taxonomy Extension Presentation Linkbase

* Filed herewith.

** Furnished herewith.

- 19-

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.    

	GLOWPOINT, INC.
May 15, 2019	By:	/s/ Peter Holst
		Peter Holst
		Chief Executive Officer
		(Principal Executive Officer)

May 15, 2019	By:	/s/ David Clark
		David Clark
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

- 20-

EX-3.5

CERTIFICATE OF AMENDMENT
TO THE

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

OF

GLOWPOINT, INC.

Glowpoint, Inc. (the “Corporation”), a corporation organized and existing under, and by virtue of, the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that:

FIRST: The name of the Corporation is Glowpoint, Inc.

SECOND: The original Certificate of Incorporation of the Corporation (the “Certificate of Incorporation”) was filed with the Secretary of State of the State of Delaware (the “Delaware Secretary”) on November 4, 1996. The Certificate of Incorporation was amended by that certain Agreement and Plan of Merger dated as of November 27, 1996 and Certificate of Amendment filed with the Delaware Secretary on May 18, 2000, and subsequently amended and restated in its entirety by the Amended and Restated Certificate of Incorporation filed with the Delaware Secretary on May 18, 2000 (such certificate, the “A&R Certificate of Incorporation”). The A&R Certificate of Incorporation was subsequently amended by the Certificate of Amendment, filed with the Delaware Secretary on May 18, 2000, Certificate of Amendment, filed with the Delaware Secretary on June 22, 2001, Certificate of Amendment, filed with the Delaware Secretary on September 24, 2003, Certificate of Amendment, filed with the Delaware Secretary on August 22, 2007, Certificate of Amendment, filed with the Delaware Secretary on June 2, 2009, and Certificate of Amendment, filed with the Delaware Secretary on January 10, 2011 (the A&R Certificate of Incorporation, as amended to date, the “Amended Certificate”).

THIRD: That at a meeting of the Board of Directors of the Corporation duly called and held on March 8, 2019, resolutions were duly adopted setting forth a proposed amendment (the “Amendment”) of the Amended Certificate of the Corporation, declaring said amendment to be advisable. The resolution setting forth the proposed amendment is as follows:

RESOLVED, that the Amended & Restated Certificate of Incorporation of the Corporation be amended by changing Article IV thereof to insert the following language at the end of such Article:

“Upon the filing and effectiveness (the “Effective Time”), pursuant to the Delaware General Corporation Law, of this Certificate of Amendment to the Certificate of Incorporation of the Corporation, each ten (10) shares of Common Stock either issued and outstanding or held by the Corporation in treasury stock immediately prior to the Effective Time shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) fully paid and nonassessable share of Common Stock (the “Reverse Stock Split”). No fractional shares shall be issued in connection with the Reverse Stock Split. In lieu of any fractional share of Common Stock to which a stockholder would otherwise be entitled in connection with the Reverse Stock Split (taking into consideration all shares of Common Stock owned by such stockholder), the Corporation will issue that number of shares of Common Stock resulting from the Reverse Stock Split as rounded up to the nearest whole share upon the submission of a transmission letter by a stockholder holding the shares in book-entry form and, where shares are held in certificated form, upon the surrender of the stockholder’s Old Certificates (as defined below). Each certificate that immediately prior to the Effective Time represented shares of Common Stock (“Old Certificates”), shall thereafter represent that number of shares of Common Stock into which the shares of Common Stock represented by the Old Certificate shall have been combined, subject to the elimination of fractional share interests as described above.

The par value per share of the Corporation’s capital stock and the total number of shares of all classes of capital stock that the Corporation is authorized to issue pursuant to this Article IV shall, in each case, not be affected by the Reverse Stock Split.

No other change to the Certificate of Incorporation is hereby made, including, without limitation, any other change to Article IV.

FOURTH: That, pursuant to a majority action by the Corporation’s Shareholders in accordance with Section 228 of the DGCL, the holders of the necessary number of shares of the Corporation’s outstanding capital stock as required by statute approved the Amendment.

FIFTH: That said Amendment was duly adopted in accordance with the provisions of Section 242 of the DGCL.

SIXTH: This Certificate of Amendment shall be effective as of April 17, 2019 at 5:00 P.M. Eastern Standard Time.

IN WITNESS WHEREOF, the Corporationhas caused this Certificate of Amendment to be signed by its authorized officer this 17th day of April, 2019.

/s/ David Clark            

Name: David Clark

Title: Authorized Officer

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Peter Holst, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Glowpoint, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 15, 2019

/s/ Peter Holst    

Peter Holst

Chief Executive Officer

(principal executive officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, David Clark, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Glowpoint, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;  and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 15, 2019

/s/ David Clark    

David Clark

Chief Financial Officer

(principal financial and accounting officer)

EX-32.1

Exhibit 32.1

SECTION 906 CERTIFICATION

The undersigned officers of Glowpoint, Inc., a Delaware corporation (the "Company"), do hereby certify, in accordance with 18 U.S.C. Section 1350, as created pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended March 31, 2019 (the "Report") fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 15, 2019

/s/ Peter Holst    

Peter Holst

Chief Executive Officer

/s/ David Clark    

David Clark

Chief Financial Officer

XML

Document and Entity Information - shares shares in Thousands	3 Months Ended
	Mar. 31, 2019	May 10, 2019
Document and Entity Information
Entity Registrant Name	GLOWPOINT, INC.
Entity Central Index Key	0000746210
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Amendment Flag	false
Smaller Reporting Company	true
Emerging Growth Company	false
Entity Common Stock, Shares Outstanding (in shares)		5,092

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash	$ 1,589	$ 2,007
Accounts receivable, net	1,442	1,371
Prepaid expenses and other current assets	619	547
Total current assets	3,650	3,925
Property and equipment, net	610	728
Goodwill	2,795	2,795
Intangibles, net	467	499
Other assets	89	15
Total assets	7,611	7,962
Current liabilities:
Accounts payable	207	222
Accrued expenses and other liabilities	1,159	910
Total current liabilities	1,366	1,132
Commitments and contingencies (see Note 9)
Stockholders’ equity:
Common stock, $.0001 par value; 150,000,000 shares authorized; 5,173,900 issued and 5,040,500 outstanding at March 31, 2019 and 5,113,700 issued and 4,981,200 outstanding at December 31, 2018	5	5
Treasury stock, 133,400 and 132,500 shares at March 31, 2019 and December 31, 2018, respectively	(497)	(496)
Additional paid-in capital	185,008	184,994
Accumulated deficit	(178,271)	(177,673)
Total stockholders’ equity	6,245	6,830
Total liabilities and stockholders’ equity	7,611	7,962
Series A-2 Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series B Preferred Stock
Stockholders’ equity:
Preferred stock	0	0
Series C Preferred Stock
Stockholders’ equity:
Preferred stock	$ 0	$ 0

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Preferred stock, convertible, shares authorized (in shares)	5,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	150,000,000	150,000,000
Common stock, shares issued (in shares)	5,173,900	5,113,700
Common stock, shares outstanding (in shares)	5,040,500	4,981,200
Treasury stock, shares (in shares)	113,400	132,500
Series A-2 Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 7,500	$ 7,500
Preferred stock, convertible, shares authorized (in shares)	7,500	7,500
Preferred stock, convertible, shares issued (in shares)	32	32
Preferred stock, convertible, shares outstanding (in shares)	32	32
Preferred stock, convertible, liquidation value	$ 323,000	$ 308,000
Series B Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 1,000	$ 1,000
Preferred stock, convertible, shares authorized (in shares)	2,800	2,800
Preferred stock, convertible, shares issued (in shares)	0	75
Preferred stock, convertible, shares outstanding (in shares)	0	75
Preferred stock, convertible, liquidation value	$ 0	$ 75,000
Series C Preferred Stock
Preferred stock, convertible, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, convertible, stated value	$ 1,000	$ 1,000
Preferred stock, convertible, shares authorized (in shares)	1,750	1,750
Preferred stock, convertible, shares issued (in shares)	475	525
Preferred stock, convertible, shares outstanding (in shares)	475	525
Preferred stock, convertible, liquidation value	$ 475,000	$ 525,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
Revenue	$ 2,594	$ 3,474
Operating expenses:
Cost of revenue (exclusive of depreciation and amortization)	1,675	2,147
Research and development	213	250
Sales and marketing	33	177
General and administrative	1,112	898
Impairment charges	0	650
Depreciation and amortization	159	232
Total operating expenses	3,192	4,354
Loss from operations	(598)	(880)
Interest and other expense, net	0	(405)
Net loss	(598)	(1,285)
Preferred stock dividends	15	3
Net loss attributable to common stockholders	$ (613)	$ (1,288)
Net loss attributable to common stockholders per share:
Basic and diluted net loss per share (in dollars per share)	$ (0.12)	$ (0.28)
Weighted-average number of shares of common stock:
Basic and diluted (in shares)	5,104	4,623

XML

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Preferred Stock Series A-2 Preferred Stock	Preferred Stock Series B Preferred Stock	Preferred Stock Series C Preferred Stock	Common Stock	Common Stock Series B Preferred Stock	Common Stock Series C Preferred Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2017		32	450		4,516,000			65,000
Beginning Balance, value at Dec. 31, 2017	$ 12,262	$ 0			$ 5			$ (352)	$ 183,114	$ (170,505)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,285)									(1,285)
Stock-based compensation	50								50
Issuance of preferred stock, net of expenses (in shares)				1,750
Issuance of preferred stock, net of expenses	1,527								1,527
Preferred stock conversion (in shares)			(75)	(475)	(185,000)
Issuance of stock on vested restricted stock units (in shares)					31,000
Preferred stock dividends	(3)								(3)
Purchase of treasury stock (in shares)								18,000
Purchase of treasury stock	(53)							$ (53)
Ending Balance (in shares) at Mar. 31, 2018		32	375	1,275	4,732,000			83,000
Ending Balance, value at Mar. 31, 2018	12,498	$ 0			$ 5			$ (405)	184,688	(171,790)
Beginning Balance (in shares) at Dec. 31, 2018		32	75	525	5,114,000			133,000
Beginning Balance, value at Dec. 31, 2018	6,830	$ 0			$ 5			$ (496)	184,994	(177,673)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(598)									(598)
Stock-based compensation	29								29
Preferred stock conversion (in shares)			(75)	(50)	(43,000)	(26,786)	(16,667)
Issuance of stock on vested restricted stock units (in shares)					17,000
Preferred stock dividends	(15)								(15)
Purchase of treasury stock	(1)							$ (1)
Ending Balance (in shares) at Mar. 31, 2019		32	0	475	5,174,000			133,000
Ending Balance, value at Mar. 31, 2019	$ 6,245	$ 0			$ 5			$ (497)	$ 185,008	$ (178,271)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net loss	$ (598)	$ (1,285)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	159	232
Bad recovery	(4)
Bad debt expense		5
Amortization of debt discount, net of gain on extinguishment	0	104
Stock-based compensation	29	50
Impairment charges	0	650
Changes in operating assets and liabilities:
Accounts receivable	(67)	(80)
Prepaid expenses and other current assets	(72)	19
Other assets	24	0
Accounts payable	(15)	(28)
Accrued expenses and other liabilities	136	(139)
Net cash used in operating activities	(408)	(472)
Cash flows from investing activities:
Purchases of property and equipment	(9)	(48)
Net cash used in investing activities	(9)	(48)
Cash flows from financing activities:
Principal payments under borrowing arrangements	0	(1,832)
Proceeds from Series C Preferred Stock issuance, net of expenses of $223	0	1,527
Purchase of treasury stock	(1)	(53)
Net cash used in financing activities	(1)	(358)
Decrease in cash and cash equivalents	(418)	(878)
Cash at beginning of period	2,007	3,946
Cash at end of period	1,589	3,068
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	0	316
Non-cash investing and financing activities:
Accrued preferred stock dividends	$ 15	$ 3

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($)
Series C Preferred Stock
Stock issuance costs	$ 223

XML

Business Description and Significant Accounting Policies

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Business Description and Significant Accounting Policies

Business Description and Significant Accounting Policies

Business Description

Glowpoint, Inc. (“Glowpoint,” “we,” “us,” or the “Company”) is a managed service provider of video collaboration and network applications. Our services are designed to provide a comprehensive suite of automated and concierge applications to simplify the user experience and expedite the adoption of video as the primary means of collaboration. Our customers include Fortune 1000 companies, along with small and medium sized enterprises in a variety of industries. We market our services globally through a multi-channel sales approach that includes direct sales and channel partners. The Company was formed as a Delaware corporation in May 2000. The Company operates in one segment and therefore segment information is not presented.

On December 20, 2018, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Glowpoint Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Glowpoint (the “Merger Sub”), and SharedLabs, Inc. (“SharedLabs”), a privately held global software and technology services company located in Jacksonville, Florida. The Merger Agreement provided for the merger of the Merger Sub with and into SharedLabs, with SharedLabs surviving as a wholly-owned subsidiary of Glowpoint (the “Merger”), in exchange for the issuance of shares of the Company’s Common Stock, par value $0.0001 per share (“Common Stock”). On April 28, 2019, the Company, the Merger Sub and SharedLabs entered into a Mutual Termination Agreement (the “Termination Agreement”), which provides for, among other things, (i) the termination of the Merger Agreement, (ii) the reservation of all rights by the Company and the Merger Sub under the Merger Agreement, applicable law or otherwise, with respect to any claims now existing or hereafter arising out of or related to the Merger Agreement, and (iii) the release by SharedLabs of the Company and the Merger Sub and certain of their affiliates from any claims up to the effective time of the Termination Agreement. SharedLabs has agreed to work with the Company in good faith to reach a resolution with respect to the Company’s rights in connection with the termination of the Merger Agreement, including the payment by SharedLabs of fees and expenses in connection therewith. To the extent it is necessary, the Company expects to utilize available legal remedies in order to pursue the payment by SharedLabs of any such amounts. There can be no assurance that the Company will be able to obtain payment by SharedLabs of any fees and expenses it owes to Glowpoint in connection with the termination of the Merger Agreement under the terms of the Merger Agreement. The Company has not recorded any amounts related to such potential recoveries as of March 31, 2019 and will record any such amounts when and if the gain contingency is resolved.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Glowpoint and our 100%-owned subsidiary, GP Communications, LLC, whose business function is to provide interstate telecommunications services for regulatory purposes. All material inter-company balances and transactions have been eliminated in consolidation.

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2018. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

The December 31, 2018 year-end condensed consolidated balance sheet data in this document was derived from audited consolidated financial statements. These condensed consolidated financial statements and notes included in this quarterly report on Form 10-Q does not include all disclosures required by U.S. generally accepted accounting principles and should be read in conjunction with the Company's audited consolidated financial statements as of and for the year ended December 31, 2018 and notes thereto included in the Company's fiscal 2018 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 8, 2019 (the “2018 10-K”).

The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

Reclassification

Certain prior year amounts have been reclassified to conform with the current year presentation.

Significant Accounting Policies

The significant accounting policies used in preparation of these condensed consolidated financial statements are disclosed in our 2018 10-K.

Leases

The Company determines if an arrangement is a lease at inception. For the Company’s operating leases, the right-of-use (“ROU”) assets represents the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Since all of the lease agreements do not provide an implicit rate, the Company estimated an incremental borrowing rate in determining the present value of the lease payments. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectations regarding the terms. Variable lease costs such as operating costs and property taxes are expensed as incurred.

Adopted Accounting Standards

In February 2016 the FASB issued ASU 2016-02, “Leases (Topic 842)”, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. On January 1, 2019, the Company adopted the new lease standard using the optional transition method under which comparative financial information will not be restated and continue to apply the provisions of the previous lease standard in its annual disclosures for the comparative periods. In addition, the new lease standard provides a number of optional practical expedients in transition. The Company elected the package of practical expedients. As such, the Company did not have to reassess whether expired or existing contracts are or contain a lease; did not have to reassess the lease classifications or reassess the initial direct costs associated with expired or existing leases.

The new lease standard also provides practical expedients for an entity's ongoing accounting. The Company elected the short-term lease recognition exemption under which the Company will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases. The Company elected the practical expedient to not separate lease and non-lease components for certain classes of assets (office buildings). For leases that qualify as short-term leases, the Company has elected to not apply the balance sheet recognition requirements of Topic 842, and instead we recognize the lease payments in the condensed consolidated statement of operations on a straight-line basis over the lease term.

On January 1, 2019, the Company recognized ROU assets and lease liabilities of approximately $99,000 and $111,000, respectively, using an estimated incremental borrowing rate of 7.75%. The ROU assets are recorded in other assets and the lease liabilities are recorded in accrued expenses on the Company’s consolidated balance sheet.

In June 2018 the FASB issued ASU 2018-07, “Compensation - Stock Compensation (Topic 718).” The guidance simplifies the accounting for share-based payments to non-employees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The new guidance expands the scope to include share-based payments granted to non-employees in exchange for goods or services used or consumed in an entity’s own operations and supersedes the guidance in ASC 505-50. Effective January 1, 2019, we adopted Topic 718 and this guidance did not have a material impact on our consolidated financial statements.

Recently Issued Accounting Pronouncements

In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The amendments introduce an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. In addition, the amendments provide for a simplified accounting model for purchased financial assets with a more-than-insignificant amount of credit deterioration since their origination. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. We believe the effect of adopting this guidance on our consolidated financial statements and related disclosures will not be material.

XML

Liquidity and Going Concern

3 Months Ended

Mar. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Liquidity and Going Concern

Liquidity and Going Concern

As of March 31, 2019, we had $1,589,000 of cash and working capital of $2,284,000. For the three months ended March 31, 2019, we incurred a net loss of $598,000 and used $408,000 of net cash in operating activities.

Our capital requirements continue to depend on numerous factors, including the timing and amount of revenue, the expense to deliver our services, expense for sales and marketing, expense for research and development, capital improvements, the number of shares repurchased under the Company’s Stock Repurchase Program, the cost involved in protecting our intellectual property rights, expenses required to successfully pursue and execute any merger and acquisition and/or business development initiatives, and, our ability to recover any damages owing from SharedLabs under the terms of the Merger Agreement. The Company believes that, based on our current projection of revenue, expenses, capital expenditures and cash flows, it has sufficient resources to fund its operations for at least the next twelve months following the filing of this Report. However, there is no assurance the Company will be able to accomplish this during this period or in the future following such period. The Company is exploring business development initiatives to leverage its technology, including pursuing organic growth and strategic growth through merger and acquisition or partnership opportunities. We anticipate negative cash flow from operations for the remainder of 2019 and we believe additional capital will be required to fund investments in product development and sales and marketing as a means to reverse our negative revenue trends. While we expect to continue to adjust our cost of revenue and other operating expenses to partially offset the impact of revenue declines associated with our legacy services, we believe additional capital will likely be necessary to fund our operations over the longer term. In the event we need access to capital to fund operations or provide growth capital, we would likely need to raise capital in one or more equity offerings. There can be no assurance that we will be successful in raising necessary capital or that any such offering will be on terms acceptable to the Company. If we are unable to raise additional capital that may be needed on terms acceptable to us, it could have a material adverse effect on the Company.

XML

Reverse Stock Split

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Reverse Stock Split

Reverse Stock Split

On April 17, 2019, the Company filed an amendment to its certificate of incorporation that effected a one-for-ten reverse stock split of the Company's issued and outstanding shares of common stock. The reverse stock split did not affect the number of authorized shares of the Company’s common stock or the par value of a share of the Company’s common stock. Proportionate adjustments were made to the per share exercise or conversion price and the number of shares issuable upon the exercise or conversion of all outstanding options and other convertible or exchangeable securities, including issued and outstanding shares of the Company’s convertible preferred stock. All shares of common stock, as well as the per share exercise or conversion price and the number of shares issuable upon the exercise or conversion of all outstanding options and other convertible or exchangeable securities, including issued and outstanding shares of the Company’s convertible preferred stock, presented in this Report have been retroactively adjusted to give effect to this reverse stock split.

Stock Repurchase Program

On July 21, 2018, the Company’s Board of Directors authorized a stock repurchase program (the “Stock Repurchase Program”) granting the Company authority to repurchase up to $750,000 of the Company’s Common Stock. Under the Company’s Stock Repurchase Program, repurchases of Common Stock may be funded using the Company’s existing cash balance and/or future cash flows through repurchases made in the open market, in privately negotiated transactions, or pursuant to other means determined by the Company, in each case as permitted by securities laws and other legal requirements. The number of shares purchased under the Stock Repurchase Program and the timing of any purchases may be based on many factors, including the level of the Company’s available cash, general business conditions, and the pricing of the Common Stock. The Stock Repurchase Program does not obligate the Company to acquire a specific number of shares and may be suspended, modified, or terminated at any time. During the three months ended March 31, 2019, the Company repurchased 23 shares of Common Stock at an aggregate cost of $30, including commissions and fees. All shares of Common Stock repurchased under the Stock Repurchase Program are recorded as treasury stock. The Stock Repurchase Program does not have an expiration date. As of March 31, 2019, the Company had $673,000 remaining under the Stock Repurchase Program.

XML

Accrued Expenses and Other Liabilities

3 Months Ended

Mar. 31, 2019

Other Liabilities Disclosure [Abstract]

Accrued Expenses and Other Liabilities

Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following (in thousands):

	March 31, 2019		December 31, 2018
Accrued professional fees	$	447	$	246
Accrued compensation costs	272		189
Accrued sales taxes and regulatory fees	157		168
Other accrued expenses	105		223
Right to use lease liability	92		—
Accrued dividends on Series A-2 Preferred Stock	86		71
Deferred rent expense	—		13
Accrued expenses and other liabilities	$	1,159	$	910

XML

Stock Repurchase Program

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Stock Repurchase Program

Reverse Stock Split

On April 17, 2019, the Company filed an amendment to its certificate of incorporation that effected a one-for-ten reverse stock split of the Company's issued and outstanding shares of common stock. The reverse stock split did not affect the number of authorized shares of the Company’s common stock or the par value of a share of the Company’s common stock. Proportionate adjustments were made to the per share exercise or conversion price and the number of shares issuable upon the exercise or conversion of all outstanding options and other convertible or exchangeable securities, including issued and outstanding shares of the Company’s convertible preferred stock. All shares of common stock, as well as the per share exercise or conversion price and the number of shares issuable upon the exercise or conversion of all outstanding options and other convertible or exchangeable securities, including issued and outstanding shares of the Company’s convertible preferred stock, presented in this Report have been retroactively adjusted to give effect to this reverse stock split.

Stock Repurchase Program

On July 21, 2018, the Company’s Board of Directors authorized a stock repurchase program (the “Stock Repurchase Program”) granting the Company authority to repurchase up to $750,000 of the Company’s Common Stock. Under the Company’s Stock Repurchase Program, repurchases of Common Stock may be funded using the Company’s existing cash balance and/or future cash flows through repurchases made in the open market, in privately negotiated transactions, or pursuant to other means determined by the Company, in each case as permitted by securities laws and other legal requirements. The number of shares purchased under the Stock Repurchase Program and the timing of any purchases may be based on many factors, including the level of the Company’s available cash, general business conditions, and the pricing of the Common Stock. The Stock Repurchase Program does not obligate the Company to acquire a specific number of shares and may be suspended, modified, or terminated at any time. During the three months ended March 31, 2019, the Company repurchased 23 shares of Common Stock at an aggregate cost of $30, including commissions and fees. All shares of Common Stock repurchased under the Stock Repurchase Program are recorded as treasury stock. The Stock Repurchase Program does not have an expiration date. As of March 31, 2019, the Company had $673,000 remaining under the Stock Repurchase Program.

XML

Preferred Stock

3 Months Ended

Mar. 31, 2019

Equity [Abstract]

Preferred Stock

Preferred Stock

Our Certificate of Incorporation authorizes us to issue up to 5,000,000 shares of preferred stock. As of March 31, 2019, there were: (i) 100 shares of Perpetual Series B-1 Preferred Stock authorized and no shares issued or outstanding; (ii) 7,500 shares of Series A-2 Convertible Preferred Stock authorized and 32 shares issued and outstanding (the “Series A-2 Preferred Stock”); (iii) 2,800 shares of 0% Series B Convertible Preferred Stock (the “Series B Preferred Stock”) authorized and no shares issued and outstanding; (iv) 1,750 shares of Series C Preferred Stock authorized and 475 shares issued and outstanding; (v) 4,000 shares of Series D Convertible Preferred Stock authorized and no shares issued or outstanding; and (vi) 100 shares of Perpetual Series B Preferred Stock authorized and no shares issued or outstanding.

Series A-2 Preferred Stock

Each share of Series A-2 Preferred Stock has a stated value of $7,500 per share (the “A-2 Stated Value”), a liquidation preference equal to the A-2 Stated Value, and is convertible at the holder’s election into common stock at a conversion price per share of $21.60 as of March 31, 2019. Therefore, each share of Series A-2 Preferred Stock is convertible into 347 shares of common stock as of March 31, 2019. The conversion price is subject to adjustment upon the occurrence of certain events set forth in our Certificate of Incorporation.

The Series A-2 Preferred Stock is subordinate to the Series B-1 Preferred Stock but senior to all other classes of equity, has weighted average anti-dilution protection and, since January 1, 2013, has been entitled to cumulative dividends at a rate of 5% per annum, payable quarterly, based on the A-2 Stated Value and payable at the option of the holder in cash or through the issuance of a number of additional shares of Series A-2 Preferred Stock with an aggregate liquidation preference equal to the dividend amount payable on the applicable dividend payment date. As of March 31, 2019, the Company has recorded $86,000 in accrued dividends in “Accrued expenses and other liabilities” on the accompanying Condensed Consolidated Balance Sheet related to the remaining Series A-2 Preferred Stock outstanding. The Company, at its option, may redeem all or a portion of the Series A-2 Preferred Stock in cash at a price per share of $8,250 per share (equal to $7,500 per share multiplied by 110%) plus all accrued and unpaid dividends.

Series B Preferred Stock

During the three months ended March 31, 2019, 75 shares (constituting all issued and outstanding shares) of Series B Preferred Stock were converted to 26,786 shares of the Company’s common stock at the conversion price of $2.80 per share. As of March 31, 2019, no shares of Series B Preferred Stock remain issued and outstanding.

Series C Preferred Stock

In January 2018, the Company closed a registered direct offering of 1,750 shares of its Series C Preferred Stock for total gross proceeds to the Company of $1,750,000. The shares of Series C Preferred Stock were sold at a price equal to their stated value of $1,000 per share and are convertible into shares of the Company’s common stock at a conversion price of $3.00 per share. During the three months ended March 31, 2019, 50 shares of Series C Preferred Stock were converted to 16,667 shares of the Company’s common stock. As of March 31, 2019, 475 shares of Series C Preferred Stock remain issued and outstanding, which are convertible to 158,333 shares of the Company’s common stock.

Subject to certain exceptions, the Company has agreed to provide the purchasers, during the period that the purchasers continue to hold Series C Preferred Stock, a right of participation for up to 100% of any future offering of its common stock or other securities or equity linked debt obligations until January 2020.

In addition, the Company has agreed that it will not enter into certain “fundamental transactions,” including transactions constituting a change of control of the Company, certain reorganization transactions or a sale of all or substantially all of the Company’s assets, except as pursuant to written agreements in form and substance satisfactory to the holders of a majority of the outstanding shares of Series C Preferred Stock including the Lead Investor and on terms with respect to the Series C Preferred Stock as set forth in the Certificate of Designation of Rights, Powers, Preferences, Privileges and Restrictions of the Series C Preferred Stock.

In accordance with ASC Topic 815, we evaluated whether our convertible preferred stock contains provisions that protect holders from declines in our stock price or otherwise couldresult in modification of the exercise price and/or shares to be issued under the respective preferred stock agreements based on a variable that is not an input to the fairvalue of a “fixed-for-fixed” option and require a derivative liability. The Company determined no derivative liability is required under ASC Topic 815 with respect to our convertible preferred stock. A contingent beneficial conversion amount is required to be calculated and recognized when and if the adjusted $21.60 conversion price of the Series A-2 Preferred Stock is adjusted to reflect a down round stock issuance. In the event there is an adjustment to the conversion price, our earnings per share calculations will be impacted by the resulting deemed dividend.

XML

Stock Based Compensation

3 Months Ended

Mar. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]

Stock Based Compensation

Stock Based Compensation

Glowpoint 2014 Equity Incentive Plan

On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company’s common stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company’s common stock, or returns thereon. A total of 440,000 shares of the Company’s common stock were initially available for issuance under the 2014 Plan. At the 2018 Annual Meeting of Stockholders held on May 31, 2018, the Company’s stockholders approved an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by 300,000 shares (the "Amendment"). As of March 31, 2019, 400 shares were available for issuance under the 2014 Plan.

Glowpoint 2007 Stock Incentive Plan

In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of March 31, 2019, options to purchase a total of 117,877 shares of common stock and 11,318 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan.

Glowpoint 2000 Stock Incentive Plan

In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the “2000 Plan”). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of March 31, 2019, options to purchase a total of 25 shares of common stock were outstanding under the 2000 Plan. No shares are available for issuance under the 2000 Plan.

Stock Options

For the three months ended March 31, 2019, no stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2019, is presented below:

	Outstanding				Exercisable
	Number of Shares Underlying Options		Weighted Average Exercise Price		Number of Shares Underlying Options	Weighted Average Exercise Price
Options outstanding, December 31, 2018	118,003		$	19.90	118,003	$	19.90
Expired	(101	)	13.18
Options outstanding, March 31, 2019	117,902		$	19.90	117,902	$	19.90

Stock-based compensation expense related to stock options was $0 for the three months ended March 31, 2019 and 2018. There is no remaining unrecognized stock-based compensation expense for stock options as of March 31, 2019.

XML

Restricted Stock Awards

3 Months Ended

Mar. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Restricted Stock Awards

Stock Based Compensation

Glowpoint 2014 Equity Incentive Plan

On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company’s common stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company’s common stock, or returns thereon. A total of 440,000 shares of the Company’s common stock were initially available for issuance under the 2014 Plan. At the 2018 Annual Meeting of Stockholders held on May 31, 2018, the Company’s stockholders approved an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by 300,000 shares (the "Amendment"). As of March 31, 2019, 400 shares were available for issuance under the 2014 Plan.

Glowpoint 2007 Stock Incentive Plan

In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of March 31, 2019, options to purchase a total of 117,877 shares of common stock and 11,318 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan.

Glowpoint 2000 Stock Incentive Plan

In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the “2000 Plan”). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of March 31, 2019, options to purchase a total of 25 shares of common stock were outstanding under the 2000 Plan. No shares are available for issuance under the 2000 Plan.

Stock Options

For the three months ended March 31, 2019, no stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2019, is presented below:

	Outstanding				Exercisable
	Number of Shares Underlying Options		Weighted Average Exercise Price		Number of Shares Underlying Options	Weighted Average Exercise Price
Options outstanding, December 31, 2018	118,003		$	19.90	118,003	$	19.90
Expired	(101	)	13.18
Options outstanding, March 31, 2019	117,902		$	19.90	117,902	$	19.90

Stock-based compensation expense related to stock options was $0 for the three months ended March 31, 2019 and 2018. There is no remaining unrecognized stock-based compensation expense for stock options as of March 31, 2019.

Restricted stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Restricted Stock Awards

Restricted Stock Awards

As of March 31, 2019, 11,318 unvested restricted stock awards were outstanding. No activity occurred related to restricted stock awards during the three months ended March 31, 2019.

Stock-based compensation expense related to restricted stock awards is allocated as follows (in thousands):

	Three Months Ended
	March 31,
	2019		2018
General and administrative	2		10
	$	2	$	10

Certain restricted stock awards have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, compensation expense is recognized over the relevant performance period. For those awards not subject to performance criteria, the cost of the restricted stock awards is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.

The remaining unrecognized stock-based compensation expense for restricted stock awards as of March 31, 2019 was $138,000. Of this amount, $1,000 relates to time-based awards with a remaining weighted average period of 0.23 years. The remaining $137,000 of unrecognized stock-based compensation expense relates to performance-based awards for which expense will be recognized upon it becoming probable that the Company will achieve defined financial targets.

XML

Restricted Stock Units

3 Months Ended

Mar. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Restricted Stock Units

Stock Based Compensation

Glowpoint 2014 Equity Incentive Plan

On May 28, 2014, the Glowpoint, Inc. 2014 Equity Incentive Plan (the “2014 Plan”) was approved by the Company’s stockholders at the Company’s 2014 Annual Meeting of Stockholders. The purpose of the 2014 Plan is to promote the success of the Company and to increase stockholder value by providing an additional means to attract, motivate, retain, and reward selected employees and other eligible persons through the grant of equity awards. Awards may be granted under the 2014 Plan to officers, employees, directors and consultants of the Company or its subsidiary. The 2014 Plan permits the grant of stock options, stock appreciation rights, restricted shares, restricted stock units, cash awards and other awards, including stock bonuses, performance stock, performance units, dividend equivalents, or similar rights to purchase or acquire shares, whether at a fixed or variable price or ratio related to the Company’s common stock, upon the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any combination thereof, or any similar securities with a value derived from the value of or related to the Company’s common stock, or returns thereon. A total of 440,000 shares of the Company’s common stock were initially available for issuance under the 2014 Plan. At the 2018 Annual Meeting of Stockholders held on May 31, 2018, the Company’s stockholders approved an amendment to the 2014 Plan to, among other things, increase the number of shares of common stock available for issuance under the 2014 Plan by 300,000 shares (the "Amendment"). As of March 31, 2019, 400 shares were available for issuance under the 2014 Plan.

Glowpoint 2007 Stock Incentive Plan

In May 2014, the Board terminated the Glowpoint 2007 Stock Incentive Plan (the “2007 Plan”). Notwithstanding the termination of the 2007 Plan, outstanding awards under the 2007 Plan will remain in effect in accordance with their terms. As of March 31, 2019, options to purchase a total of 117,877 shares of common stock and 11,318 shares of restricted stock were outstanding under the 2007 Plan. No shares are available for issuance under the 2007 Plan.

Glowpoint 2000 Stock Incentive Plan

In June 2010, the Board terminated the Glowpoint 2000 Stock Incentive Plan (as amended, the “2000 Plan”). Notwithstanding the termination of the 2000 Plan, outstanding awards under the 2000 Plan will remain in effect in accordance with their terms. As of March 31, 2019, options to purchase a total of 25 shares of common stock were outstanding under the 2000 Plan. No shares are available for issuance under the 2000 Plan.

Stock Options

For the three months ended March 31, 2019, no stock options were granted; therefore, no fair value assumptions are presented herein. A summary of stock options expired under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2019, is presented below:

	Outstanding				Exercisable
	Number of Shares Underlying Options		Weighted Average Exercise Price		Number of Shares Underlying Options	Weighted Average Exercise Price
Options outstanding, December 31, 2018	118,003		$	19.90	118,003	$	19.90
Expired	(101	)	13.18
Options outstanding, March 31, 2019	117,902		$	19.90	117,902	$	19.90

Stock-based compensation expense related to stock options was $0 for the three months ended March 31, 2019 and 2018. There is no remaining unrecognized stock-based compensation expense for stock options as of March 31, 2019.

Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Restricted Stock Units

Restricted Stock Units

A summary of unvested restricted stock units (“RSUs”) outstanding as of, and changes made during, the three months ended March 31, 2019, is presented below:

	RSUs		Weighted Average Grant Price
Unvested restricted stock units outstanding, December 31, 2018	503,511		$	1.94
Granted	52,976		1.31
Vested	(16,826	)	8.37
Forfeited	(267	)	1.31
Unvested restricted stock units outstanding, March 31, 2019	539,394		$	1.68

The number of restricted stock units vested during the three months ended March 31, 2019 includes 877 shares withheld and repurchased by the Company from employees to satisfy $1,000 of tax obligations relating to the vesting of such shares. Such shares are included in “Purchase of treasury stock” during the three months ended March 31, 2019.

As of March 31, 2019, 98,763 vested RSUs issued to non-employee directors remain outstanding as shares of common stock have not yet been delivered due to the deferred payment provisions set forth in these RSUs.

As of March 31, 2019, 497,061 unvested RSUs have performance-based vesting provisions and are subject to forfeiture, in whole or in part, if these performance conditions are not achieved. Management assesses, on an ongoing basis, the probability of whether the performance criteria will be achieved and, once it is deemed probable, stock-based compensation expense is recognized over the relevant performance period. As of March 31, 2019, 42,333 unvested RSUs have timed-based vesting provisions, and the cost of the RSUs is expensed, which is determined to be the fair market value of the shares at the date of grant, on a straight-line basis over the vesting period.

Stock-based compensation expense related to RSUs is allocated as follows (in thousands):

	Three Months Ended
	March 31,
	2019		2018
Cost of revenue	$	4	$	5
Research and development	4		10
Sales and marketing	—		2
General and administrative	19		23
	$	27	$	40

The remaining unrecognized stock-based compensation expense for RSUs as of March 31, 2019 was $666,000. Of this amount $29,000 relates to time-based RSUs with a remaining weighted average period of 1.05 years. The remaining $637,000 of unrecognized stock-based compensation expense relates to performance-based RSUs for which expense will be recognized upon it becoming probable that the Company achieves defined financial targets or a change of control occurs.

XML

Net Loss Per Share

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Net Loss Per Share

Net Loss Per Share

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. The weighted-average number of shares of common stock outstanding does not include any potentially dilutive securities or unvested restricted stock. Unvested restricted stock, although classified as issued and outstanding at March 31, 2019 and 2018, is considered contingently returnable until the restrictions lapse and will not be included in the basic net loss per share calculation until the shares are vested. Unvested restricted stock does not contain non-forfeitable rights to dividends and dividend equivalents. Unvested RSUs are not included in calculations of basic net loss per share, as they are not considered issued and outstanding at time of grant.

Diluted net loss per share is computed by giving effect to all potential shares of common stock, including stock options, preferred stock, RSUs, and unvested restricted stock, to the extent they are dilutive. For the three months ended March 31, 2019 and 2018, all such common stock equivalents have been excluded from diluted net loss per share as the effect to net loss per share would be anti-dilutive (due to the net loss).

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):

	Three Months Ended March 31,
	2019			2018
Numerator:
Net loss	$	(598	)	$	(1,285	)
Less: preferred stock dividends	15			3
Net loss attributable to common stockholders	$	(613	)	$	(1,288	)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share	5,104			4,623
Basic and diluted net loss per share	$	(0.12	)	$	(0.28	)

The weighted-average number of shares for all periods presented includes 98,763 shares of vested RSUs, respectively, as discussed in Note 7.

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect:

	Three Months Ended March 31,
	2019	2018
Unvested restricted stock units	539,394	98,944
Unvested restricted stock awards	11,318	11,318
Outstanding stock options	117,902	119,179
Shares of common stock issuable upon conversion of Series A-2 Preferred	79,043	79,043
Shares of common stock issuable upon conversion of Series B Preferred	—	133,929
Shares of common stock issuable upon conversion of Series C Preferred	158,333	425,000

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Operating Leases

We lease two facilities in Denver, CO and Oxnard, CA that are under operating leases through December 31, 2019 and April 30, 2020, respectively. Both of these leases require us to pay increases in real estate taxes, operating costs and repairs over certain base year amounts. Rent expense for the three months ended March 31, 2019 and 2018 was $52,000 and $74,000, respectively, and is included in general and administrative expenses in the accompanying consolidated statements of operations.

Future minimum rental commitments under all non-cancelable operating leases as of March 31, 2019, are as follows (in thousands):

Year Ending December 31,	Short-Term Lease		ROU Lease		Total
Remaining 2019	$	61	$	66	$	127
2020	—		30		30
	$	61	$	96	$	157

The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands):

Year Ending December 31,
Remaining 2019	$	66
2020	30
Total cash payments remaining	$	96
Effect of discounting	(4		)
Total accrued lease liability	$	92

Operating cash flow supplemental information as of March 31, 2019:

On January 1, 2019, initial ROU assets of $99,000 were recognized as a non-cash addition with the adoption of the new lease standard. Cash paid for amounts included in the present value of the operating lease liabilities was $22,000 which was included within accrued expenses for the three months ended March 31, 2019.

XML

Major Customers

3 Months Ended

Mar. 31, 2019

Risks and Uncertainties [Abstract]

Major Customers

Major Customers

Major customers are defined as direct customers or channel partners that account for more than 10% of the Company’s revenue. For the three months ended March 31, 2019, three major customers represented 28%, 21%, and 10%, respectively, of our revenue. Three customers represented 48%, 15%, and 11%, respectively, of our accounts receivable balance at March 31, 2019. For the three months ended March 31, 2018, two major customers represented 24% and 23%, respectively, of our revenue.

XML

Geographical Data

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Geographical Data

Geographical Data

For the three months ended March 31, 2019 and 2018, there was no material revenue attributable to any individual foreign country. Revenue by geographic area, based on customer location, is allocated as follows (in thousands):

	Three Months Ended March 31,
	2019		2018
Domestic	$	1,796	$	2,269
Foreign	798		1,205
Total Revenue	$	2,594	$	3,474

Long-lived assets were 100% located in domestic markets as of March 31, 2019 and December 31, 2018.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

On April 17, 2019, the Company filed an amendment to its certificate of incorporation that effected a one-for-ten reverse stock split of the Company's issued and outstanding shares of common stock. See Note 3 for further discussion.

On April 28, 2019, the Company, the Merger Sub and SharedLabs entered into the Termination Agreement, under which the parties agreed, among other things, to terminate the Merger Agreement effective as of April 28, 2019. See Note 1 for further discussion.

XML

Business Description and Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Principles of Consolidation

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Glowpoint and our 100%-owned subsidiary, GP Communications, LLC, whose business function is to provide interstate telecommunications services for regulatory purposes. All material inter-company balances and transactions have been eliminated in consolidation.

Basis of Presentation

Basis of Presentation

The Company's fiscal year ends on December 31 of each calendar year. The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as our annual consolidated financial statements for the fiscal year ended December 31, 2018. In the opinion of the Company's management, these interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.

Reclassification

Reclassification

Certain prior year amounts have been reclassified to conform with the current year presentation.

Leases

Leases

The Company determines if an arrangement is a lease at inception. For the Company’s operating leases, the right-of-use (“ROU”) assets represents the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent an obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Since all of the lease agreements do not provide an implicit rate, the Company estimated an incremental borrowing rate in determining the present value of the lease payments. Operating lease expense is recognized on a straight-line basis over the lease term, subject to any changes in the lease or expectations regarding the terms. Variable lease costs such as operating costs and property taxes are expensed as incurred.

Adopted Accounting Standards and Recently Issued Accounting Pronouncements

Adopted Accounting Standards

In February 2016 the FASB issued ASU 2016-02, “Leases (Topic 842)”, which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. On January 1, 2019, the Company adopted the new lease standard using the optional transition method under which comparative financial information will not be restated and continue to apply the provisions of the previous lease standard in its annual disclosures for the comparative periods. In addition, the new lease standard provides a number of optional practical expedients in transition. The Company elected the package of practical expedients. As such, the Company did not have to reassess whether expired or existing contracts are or contain a lease; did not have to reassess the lease classifications or reassess the initial direct costs associated with expired or existing leases.

The new lease standard also provides practical expedients for an entity's ongoing accounting. The Company elected the short-term lease recognition exemption under which the Company will not recognize ROU assets or lease liabilities, and this includes not recognizing ROU assets or lease liabilities for existing short-term leases. The Company elected the practical expedient to not separate lease and non-lease components for certain classes of assets (office buildings). For leases that qualify as short-term leases, the Company has elected to not apply the balance sheet recognition requirements of Topic 842, and instead we recognize the lease payments in the condensed consolidated statement of operations on a straight-line basis over the lease term.

On January 1, 2019, the Company recognized ROU assets and lease liabilities of approximately $99,000 and $111,000, respectively, using an estimated incremental borrowing rate of 7.75%. The ROU assets are recorded in other assets and the lease liabilities are recorded in accrued expenses on the Company’s consolidated balance sheet.

In June 2018 the FASB issued ASU 2018-07, “Compensation - Stock Compensation (Topic 718).” The guidance simplifies the accounting for share-based payments to non-employees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The new guidance expands the scope to include share-based payments granted to non-employees in exchange for goods or services used or consumed in an entity’s own operations and supersedes the guidance in ASC 505-50. Effective January 1, 2019, we adopted Topic 718 and this guidance did not have a material impact on our consolidated financial statements.

Recently Issued Accounting Pronouncements

In June 2016 the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326).” The amendments introduce an impairment model that is based on expected credit losses, rather than incurred losses, to estimate credit losses on certain types of financial instruments (e.g., loans and held-to-maturity securities), including certain off-balance sheet financial instruments (e.g., loan commitments). The expected credit losses should consider historical information, current information, and reasonable and supportable forecasts, including estimates of prepayments, over the contractual term. Financial instruments with similar risk characteristics may be grouped together when estimating expected credit losses. In addition, the amendments provide for a simplified accounting model for purchased financial assets with a more-than-insignificant amount of credit deterioration since their origination. The update is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. We believe the effect of adopting this guidance on our consolidated financial statements and related disclosures will not be material.

XML

Accrued Expenses and Other Liabilities (Tables)

3 Months Ended

Mar. 31, 2019

Other Liabilities Disclosure [Abstract]

Schedule of Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consisted of the following (in thousands):

	March 31, 2019		December 31, 2018
Accrued professional fees	$	447	$	246
Accrued compensation costs	272		189
Accrued sales taxes and regulatory fees	157		168
Other accrued expenses	105		223
Right to use lease liability	92		—
Accrued dividends on Series A-2 Preferred Stock	86		71
Deferred rent expense	—		13
Accrued expenses and other liabilities	$	1,159	$	910

XML

Stock Based Compensation (Tables)

3 Months Ended

Mar. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]

Summary of Stock Option Activity

A summary of stock options expired under our stock incentive plans and stock options outstanding as of, and changes made during, the three months ended March 31, 2019, is presented below:

	Outstanding				Exercisable
	Number of Shares Underlying Options		Weighted Average Exercise Price		Number of Shares Underlying Options	Weighted Average Exercise Price
Options outstanding, December 31, 2018	118,003		$	19.90	118,003	$	19.90
Expired	(101	)	13.18
Options outstanding, March 31, 2019	117,902		$	19.90	117,902	$	19.90

XML

Restricted Stock Awards (Tables)

3 Months Ended

Mar. 31, 2019

Restricted stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Compensation Expense

Stock-based compensation expense related to restricted stock awards is allocated as follows (in thousands):

	Three Months Ended
	March 31,
	2019		2018
General and administrative	2		10
	$	2	$	10

XML

Restricted Stock Units (Tables) - Restricted Stock Units (RSUs)

3 Months Ended

Mar. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of Restricted Stock Units Activity

A summary of unvested restricted stock units (“RSUs”) outstanding as of, and changes made during, the three months ended March 31, 2019, is presented below:

	RSUs		Weighted Average Grant Price
Unvested restricted stock units outstanding, December 31, 2018	503,511		$	1.94
Granted	52,976		1.31
Vested	(16,826	)	8.37
Forfeited	(267	)	1.31
Unvested restricted stock units outstanding, March 31, 2019	539,394		$	1.68

Summary of Compensation Expense

Stock-based compensation expense related to RSUs is allocated as follows (in thousands):

	Three Months Ended
	March 31,
	2019		2018
Cost of revenue	$	4	$	5
Research and development	4		10
Sales and marketing	—		2
General and administrative	19		23
	$	27	$	40

XML

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2019

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of the Company’s basic and diluted net loss per share (in thousands, except per share data):

	Three Months Ended March 31,
	2019			2018
Numerator:
Net loss	$	(598	)	$	(1,285	)
Less: preferred stock dividends	15			3
Net loss attributable to common stockholders	$	(613	)	$	(1,288	)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share	5,104			4,623
Basic and diluted net loss per share	$	(0.12	)	$	(0.28	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table represents the potential shares that were excluded from the computation of weighted-average number of shares of common stock in computing the diluted net loss per share for the periods presented because including them would have had an anti-dilutive effect:

	Three Months Ended March 31,
	2019	2018
Unvested restricted stock units	539,394	98,944
Unvested restricted stock awards	11,318	11,318
Outstanding stock options	117,902	119,179
Shares of common stock issuable upon conversion of Series A-2 Preferred	79,043	79,043
Shares of common stock issuable upon conversion of Series B Preferred	—	133,929
Shares of common stock issuable upon conversion of Series C Preferred	158,333	425,000

XML

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Commitments, Non-Cancelable Operating Leases

Future minimum rental commitments under all non-cancelable operating leases as of March 31, 2019, are as follows (in thousands):

Year Ending December 31,	Short-Term Lease		ROU Lease		Total
Remaining 2019	$	61	$	66	$	127
2020	—		30		30
	$	61	$	96	$	157

Summary of Future Undiscounted Cash Payments

The following table summarizes the future undiscounted cash payments reconciled to the lease liability (in thousands):

Year Ending December 31,
Remaining 2019	$	66
2020	30
Total cash payments remaining	$	96
Effect of discounting	(4		)
Total accrued lease liability	$	92

XML

Geographical Data (Tables)

3 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Schedule of Revenue by Geographical Area

Revenue by geographic area, based on customer location, is allocated as follows (in thousands):

	Three Months Ended March 31,
	2019		2018
Domestic	$	1,796	$	2,269
Foreign	798		1,205
Total Revenue	$	2,594	$	3,474

XML

Business Description and Significant Accounting Policies - Narrative (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2019 segment $ / shares	Jan. 01, 2019 USD ($)	Dec. 31, 2018 $ / shares	Dec. 20, 2018 $ / shares
Business Acquisition [Line Items]
Number of operating segments | segment	1
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001		$ 0.0001
Ownership percentage in subsidiary	100.00%
Right-of-use assets | $		$ 99
Lease liabilities | $		$ 111
Estimated incremental borrowing rate		7.75%
SharedLabs
Business Acquisition [Line Items]
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001

XML

Liquidity and Going Concern - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 1,589		$ 2,007
Working capital	2,284
Net loss	598	$ 1,285
Net cash used in operating activities	$ 408	$ 472

XML

Reverse Stock Split - Narrative (Details)	Apr. 17, 2019
Subsequent Event | Common Stock
Class of Stock [Line Items]
Stock split ratio, common stock	0.1

XML

Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Dec. 31, 2018
Accrued Expenses, Current [Abstract]
Accrued professional fees	$ 447	$ 246
Accrued compensation costs	272	189
Accrued sales taxes and regulatory fees	157	168
Other accrued expenses	105	223
Right to use lease liability	92
Accrued dividends on Series A-2 Preferred Stock	86	71
Deferred rent expense	0	13
Accrued expenses and other liabilities	$ 1,159	$ 910

XML

Stock Repurchase Program - Narrative (Details) - Stock Repurchase Program - USD ($)	3 Months Ended
	Mar. 31, 2019	Jul. 21, 2018
Class of Stock [Line Items]
Number of shares authorized to be repurchased (in shares)		750,000
Stock repurchased (in shares)	23
Stock repurchased, value	$ 30
Remaining authorized repurchase amount	$ 673,000

XML

Preferred Stock - Narrative (Details) - USD ($)	1 Months Ended	3 Months Ended
	Jan. 31, 2018	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)		5,000,000
Accrued dividends on Series A-2 Preferred Stock		$ 86,000		$ 71,000
Proceeds from issuance of preferred stock gross		$ 0	$ 1,527,000
Common Stock
Class of Stock [Line Items]
Stock issued for conversion of convertible preferred stock, shares (in shares)		43,000	185,000
Perpetual Series B-1 Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)		100
Preferred stock, shares issued (in shares)		0
Preferred stock, shares outstanding (in shares)		0
Series A-2 Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)		7,500		7,500
Preferred stock, shares issued (in shares)		32		32
Preferred stock, cumulative dividend percentage rate, per annum		5.00%
Preferred stock, stated value		$ 7,500		$ 7,500
Stock issued during period, conversion of convertible securities, price (in dollars per share)		$ 21.60
Preferred stock, shares outstanding (in shares)		32		32
Convertible preferred stock, shares issued upon conversion (in shares)		347
Redemption price per share (in dollars per share)		$ 8,250
Redemption price per share, multiplier (in dollars per share)		$ 7,500
Redemption price per share, multiplier, percentage		110.00%
Stated value (in dollars per share)		$ 0.0001		$ 0.0001
Derivative liability		$ 0
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)		2,800		2,800
Preferred stock, shares issued (in shares)		0		75
Preferred stock, cumulative dividend percentage rate, per annum		0.00%
Preferred stock, stated value		$ 1,000		$ 1,000
Stock issued during period, conversion of convertible securities, price (in dollars per share)		$ 2.80
Preferred stock, shares outstanding (in shares)		0		75
Stated value (in dollars per share)		$ 0.0001		$ 0.0001
Series B Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Stock issued for conversion of convertible preferred stock, shares (in shares)		75	75
Series B Preferred Stock | Common Stock
Class of Stock [Line Items]
Stock issued for conversion of convertible preferred stock, shares (in shares)		26,786
Series C Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)		1,750		1,750
Preferred stock, shares issued (in shares)		475		525
Preferred stock, stated value		$ 1,000		$ 1,000
Stock issued during period, conversion of convertible securities, price (in dollars per share)	$ 3.00
Preferred stock, shares outstanding (in shares)		475		525
Proceeds from issuance of preferred stock gross	$ 1,750,000
Stated value (in dollars per share)	$ 1,000	$ 0.0001		$ 0.0001
Participation rights, future offerings, max percentage	100.00%
Series C Preferred Stock | Preferred Stock
Class of Stock [Line Items]
Stock issued for conversion of convertible preferred stock, shares (in shares)		50	475
Issuance of stock (in shares)	1,750		1,750
Series C Preferred Stock | Common Stock
Class of Stock [Line Items]
Convertible preferred stock, shares issued upon conversion (in shares)		158,333
Stock issued for conversion of convertible preferred stock, shares (in shares)		16,667
Series D Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)		4,000
Preferred stock, shares issued (in shares)		0
Preferred stock, shares outstanding (in shares)		0
Perpetual Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, convertible, shares authorized (in shares)		100
Preferred stock, shares issued (in shares)		0
Preferred stock, shares outstanding (in shares)		0

XML

Stock Based Compensation - Narrative (Details)		3 Months Ended
	May 31, 2018 shares	Mar. 31, 2019 USD ($) shares	Mar. 31, 2018 USD ($)	Dec. 31, 2018 shares	May 28, 2014 event shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding number of shares underlying options (in shares)		117,902.000		118,003
Options granted (in shares)		0
Unrecognized stock-based compensation expense | $		$ 0
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense | $		$ 0	$ 0
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding (in shares)		11,318
Stock-based compensation expense | $		$ 2,000	$ 10,000
Equity Incentive Plan, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares)		400			440,000
Additional shares available for issuance (in shares)	300,000
Equity Incentive Plan, 2014 | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of events to occur to permit granting (or more) | event					1
Stock Incentive Plan, 2007 | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares)		0
Outstanding number of shares underlying options (in shares)		117,877
Stock Incentive Plan, 2007 | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding (in shares)		11,318
Stock Incentive Plan, 2000 | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares)		0
Shares outstanding (in shares)		25

XML

Stock Based Compensation - Options Outstanding (Details)	3 Months Ended
	Mar. 31, 2019 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding Number of Shares Underlying Options, Beginning ( in shares) | shares	118,003
Outstanding Number of Shares Underlying Options, Expired (in shares) | shares	(101)
Outstanding Number of Shares Underlying Options, Ending (in shares) | shares	117,902.000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding Weighted Average Exercise Price, Beginning (in dollars per share) | $ / shares	$ 19.90
Outstanding Weighted Average Exercise Price, Expired (in dollars per share) | $ / shares	13.18
Outstanding Weighted Average Exercise Price, Ending (in dollars per share) | $ / shares	$ 19.90
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable [Abstract]
Exercisable Number of Shares Underlying Options, Beginning (in shares) | shares	118,003
Exercisable Number of Shares Underlying Options, Ending (in shares) | shares	117,902
Exercisable Weighted Average Exercise Price, Beginning (in dollars per share) | $ / shares	$ 19.90
Exercisable Weighted Average Exercise Price, Ending (in dollars per share) | $ / shares	$ 19.90

XML

Restricted Stock Awards - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($) shares
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested units outstanding (in shares) | shares	11,318
Unrecognized stock-based compensation expense	$ 138
Time-based Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	$ 1
Weighted average period for amortization of unrecognized stock-based compensation	85 days
Performance-based Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	$ 137

XML

Restricted Stock Awards - Summary of Stock-Based Compensation Expense (Details) - Restricted stock - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 2	$ 10
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 2	$ 10

XML

Restricted Stock Units - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs)	3 Months Ended
	Mar. 31, 2019 $ / shares shares
Restricted Stock Units, Number of Shares [Roll Forward]
Unvested restricted units outstanding, beginning (in shares) | shares	503,511
Granted, restricted units (in shares) | shares	52,976
Vested, restricted units (in shares) | shares	(16,826)
Forfeited, restricted units (in shares) | shares	(267)
Unvested restricted units outstanding, ending (in shares) | shares	539,394
Restricted Stock Units, Weighted Average Grant Price [Roll Forward]
Unvested restricted units, weighted average grant price, beginning (in dollars per share) | $ / shares	$ 1.94
Granted, weighted average grant price (in dollars per share) | $ / shares	1.31
Vested, weighted average grant price (in dollars per share) | $ / shares	8.37
Forfeited, weighted average grant price (in dollars per share) | $ / shares	1.31
Unvested restricted units, weighted average grant price, ending (in dollars per share) | $ / shares	$ 1.68

XML

Restricted Stock Units - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Vested deferred restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested and remaining outstanding (in shares)	98,763	98,763
Unvested units outstanding (in shares)	539,394		503,511
Unrecognized stock-based compensation expense	$ 666
Performance-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested units outstanding (in shares)	497,061
Unrecognized stock-based compensation expense	$ 637
Time-based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested units outstanding (in shares)	42,333
Unrecognized stock-based compensation expense	$ 29
Weighted average period for amortization of unrecognized stock-based compensation	12 months 20 days
Non-Employee Directors | Vested deferred restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested and remaining outstanding (in shares)	98,763
Shares Withheld and Repurchased | Vested deferred restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares withheld and repurchased to satisfy tax obligation (in shares)	877
Statutory tax withholding requirements	$ 1

XML

Restricted Stock Units - Summary of Stock-Based Compensation Expense (Details) - Restricted Stock Units (RSUs) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 27	$ 40
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	4	5
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	4	10
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	0	2
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 19	$ 23

XML

Net Loss Per Share - Narrative (Details) - shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of weighted-average shares outstanding, not including potentially dilutive securities or unvested restricted stock (in shares)	0
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested and remaining outstanding (in shares)	98,763	98,763

XML

Net Loss Per Share - Computation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Numerator:
Net loss	$ (598)	$ (1,285)
Less: preferred stock dividends	15	3
Net loss attributable to common stockholders	$ (613)	$ (1,288)
Denominator:
Weighted-average number of shares of common stock for basic and diluted net loss per share (in shares)	5,104	4,623
Basic and diluted net loss per share (in dollars per share)	$ (0.12)	$ (0.28)

XML

Net Loss Per Share - Effect of Antidilutive Securities (Details) - shares	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Unvested restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	539,394	98,944
Unvested restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	11,318	11,318
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	117,902	119,179
Shares of common stock issuable upon conversion of Series A-2 Preferred
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	79,043	79,043
Shares of common stock issuable upon conversion of Series B Preferred
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	133,929
Shares of common stock issuable upon conversion of Series C Preferred
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	158,333	425,000

XML

Commitments and Contingencies - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2019 USD ($) facility	Mar. 31, 2018 USD ($)	Jan. 01, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Number of leased facilities | facility	2
Rent expense	$ 52	$ 74
Initial ROU assets, recognized as non-cash addition			$ 99
Present value of operating lease liability	$ 22

XML

Commitments and Contingencies - Future Minimum Rental Commitments (Details) $ in Thousands	Mar. 31, 2019 USD ($)
Lessee, Lease, Description [Line Items]
Remaining 2019	$ 127
2020	30
Total cash payments remaining	157
Short-Term Lease
Lessee, Lease, Description [Line Items]
Remaining 2019	61
2020	0
Total cash payments remaining	61
ROU Lease
Lessee, Lease, Description [Line Items]
Remaining 2019	66
2020	30
Total cash payments remaining	$ 96

XML

Commitments and Contingencies - Future Undiscounted Cash Payments (Details) - USD ($) $ in Thousands	Mar. 31, 2019	Jan. 01, 2019
Lessee, Lease, Description [Line Items]
Remaining 2019	$ 127
2020	30
Total cash payments remaining	157
Total accrued lease liability		$ 111
ROU Lease
Lessee, Lease, Description [Line Items]
Remaining 2019	66
2020	30
Total cash payments remaining	96
Effect of discounting	(4)
Total accrued lease liability	$ 92

XML

Major Customers - Narrative (Details) - Customer Concentration Risk - customer	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenues
Concentration Risk [Line Items]
Number of customers	3	2
Revenues | Customer No. 1
Concentration Risk [Line Items]
Concentration risk percentage	28.00%	24.00%
Revenues | Customer No. 2
Concentration Risk [Line Items]
Concentration risk percentage	21.00%	23.00%
Revenues | Customer No. 3
Concentration Risk [Line Items]
Concentration risk percentage	10.00%
Accounts Receivable
Concentration Risk [Line Items]
Number of customers	3
Accounts Receivable | Customer No. 1
Concentration Risk [Line Items]
Concentration risk percentage	48.00%
Accounts Receivable | Customer No. 2
Concentration Risk [Line Items]
Concentration risk percentage	15.00%
Accounts Receivable | Customer No. 3
Concentration Risk [Line Items]
Concentration risk percentage	11.00%

XML

Geographical Data - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Segment Reporting [Abstract]
Material revenue attributable to individual foreign country	$ 0	$ 0
Long lived assets located in domestic markets	100.00%		100.00%

XML

Geographical Data - Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Segment Reporting Information [Line Items]
Total Revenue	$ 2,594	$ 3,474
Domestic
Segment Reporting Information [Line Items]
Total Revenue	1,796	2,269
Foreign
Segment Reporting Information [Line Items]
Total Revenue	$ 798	$ 1,205

XML

Subsequent Events - Narrative (Details)	Apr. 17, 2019
Common Stock | Subsequent Event
Subsequent Event [Line Items]
Stock split ratio, common stock	0.1